Abstract
There are approximately 260 known species in the genus Millettia, many of which are used in traditional medicine to treat human and other animal ailments in various parts of the world. Being in the Leguminosae (Fabaceae) family, Millettia species are rich sources of isoflavonoids. In the past three decades alone, several isoflavonoids originating from Millettia have been isolated, and their pharmacological activities have been evaluated against major diseases, such as cancer, inflammation, and diabetes. Despite such extensive research, no recent and comprehensive review of the phytochemistry and pharmacology of Millettia isoflavonoids is available. Furthermore, the structural diversity of isoflavonoids in Millettia species has rarely been reported. In this review, we comprehensively summarized the structural diversity of Millettia isoflavonoids, the methods used for their extraction and isolation protocols, and their pharmacological properties. According to the literature, 154 structurally diverse isoflavonoids were isolated and reported from the various tissues of nine well-known Millettia species. Prenylated isoflavonoids and rotenoids were the most dominant subclasses of isoflavonoids reported. Other subclasses of reported isoflavonoids include isoflavans, aglycone isoflavones, glycosylated isoflavones, geranylated isoflavonoids, phenylcoumarins, pterocarpans and coumaronochromenes. Although some isolated molecules showed promising pharmacological properties, such as anticancer, anti-inflammatory, estrogenic, and antibacterial activities, others remained untested. In general, this review highlights the potential of Millettia isoflavonoids and could improve their utilization in drug discovery and medicinal use processes.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11101-022-09845-w.
Keywords: Isoflavonoids, Isolation, Millettia species, Pharmacological effect, Structural diversity
Introduction
Isoflavonoids, also known as 3-phenylchromanes, are a class of flavonoids found in the Leguminosae (Fabaceae) family (Veitch 2013). Although isoflavonoids are considered biomarkers of the legume species, their presence has been confirmed in more than 20 non-leguminous plant families, including Rutaceae, Iridaceae, Asteraceae, Cyperaceae, Convolvulaceae, and Asclepiadaceae, among others (Mackova et al. 2006; Raynaud et al. 2005). Structurally, flavonoids contain a 15-carbon backbone arranged as C6-C3-C6, where the two phenyl rings (known as the A-ring and B-ring) are linked by a heterocyclic pyran ring called the C-ring. Isoflavonoids also share this basic chromophore in their structure. However, unlike the other classes of flavonoids, the phenyl B-ring is attached to position 3 of the heterocyclic C-ring rather than position 2 (Fig. 1), giving rise to the name 3-phenylchromane flavonoids (Botta et al. 2009; Tsimogiannis and Oreopoulou 2019).
Fig. 1.
Structural chromophores and classification of isoflavonoids. Isoflavones, isoflavanones, isoflavan-4-ols and isoflav-3-ens follow a similar carbon numbering as isoflavans
As in many flavonoids, the oxidation state and hydroxylation pattern of the C-ring make isoflavonoids structurally diverse (Sisa et al. 2010; Tsimogiannis and Oreopoulou 2019). As illustrated in Fig. 1, at least ten subclasses of isoflavonoids are known, including isoflavans, isoflavanones, isoflav-3-ens, isoflavan-4-ols, isoflavones, rotenoids, coumarins, coumestans, coumaronochromenes, and pterocarpans. Such structural diversity of naturally occurring isoflavonoids makes them exert several health-promoting and disease-prevention properties (Bhargavan et al. 2009; Farajzadeh-Dehkordi et al. 2021; Yamaki et al. 2002). For example, in the aftermath of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease (COVID-19), several flavonoids have been studied for their ability to combat the spread of the virus. As a result, isoflavonoids such as glisoflavanone, 5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl) isoflavone, and kraussianones 2 have been shown to bind to angiotensin-converting enzyme 2 (ACE-2), making them ideal drug candidates for the treatment of COVID-19 (Alesawy et al. 2021; Prasansuklab et al. 2021; T-ul et al. 2020). Furthermore, other isoflavonoids have been discovered to have anticancer, anti-HIV, and antidiabetic properties, highlighting the potential of natural isoflavonoids in combating the most difficult human ailments (Cayetano-Salazar et al., 2021; Hussain and Green 2017; Stevenson et al. 2018). The biosynthesis of flavonoids in legumes follows the phenylpropanoid pathway, where various enzymes participate in the production of diverse classes of flavonoids (Sohn et al. 2021). As shown in Scheme 1, the interdependent actions of two enzymes called chalcone isomerase (CHI) and isoflavone synthase (IFS) led to the synthesis of the basic chromophore of isoflavonoids, and the subsequent actions of other enzymes led to the synthesis of their subclasses. Other articles provide additional information, such as the actions of specific enzymes and intermediates involved in each step (Jung et al. 2000; Yu and McGonigle 2005).
Scheme 1.

General biosynthetic pathways of isoflavonoids in legumes CHI: Chalcone isomerase; IFS: isoflavone synthase
Millettia is a genus of over 260 species in the legume family. Millettia species, as members of the legume family, are known to be rich sources of several classes of isoflavonoids. Many of the Millettia species are widely distributed in tropical and subtropical regions and have been used in traditional medicine to treat a variety of human and other animal ailments. For instance, the different tissues of Millettia dura are used to treat menstrual irregularities in different parts of Africa (Ngameni et al. 2013). Likewise, M. pachycarpa is used to control agricultural pests and for the treatment of cancer in several Asian countries (Ningombam et al. 2017; Roy and Bharti 2020). Previously, several review papers documented the medicinal uses and geographical distributions of Millettia species (Banzouzi et al. 2008; Jena et al. 2020). In recent years, there has been much interest in isolating metabolites from Millettia species and evaluating their pharmacological properties. This is partly because of technological advancements in the analysis of medicinal plants (Fitzgerald et al. 2020). In contrast, only a few review papers covering the progress of Millettia isoflavonoid research are available. Furthermore, the literature lacks depth in demonstrating the structural diversity and characterization of Millettia isoflavonoids. For instance, a recent review on the genus Millettia by Jena et al. (2020) covered less than 30 individual isoflavonoids and barely highlighted their structural diversity and pharmacological properties. Another review covered only two Millettia species, M. dura and M. ferruginea, and the isoflavonoids were barely characterized (Buyinza et al. 2020). Because of their abundance in Millettia species, isoflavonoids require separate consideration to provide a clear picture of their structural diversity, pharmacological properties, and advancements in their extraction and isolation processes. Therefore, a more comprehensive review that takes into account a large number of Millettia species could provide a better understanding of the structural diversity, distribution, and pharmacological properties of Millettia isoflavonoids. Furthermore, such a review could identify the research gaps and spark further research into the potential and applications of Millettia species and their isoflavonoids in drug discovery and medical applications. Accordingly, we focused on nine popular Millettia species, including M. brandisiana, M. griffithii, M. extensa, M. dielsiana, M. dura, M. griffoniana, M. nitida, M. pachycarpa, and M. usaramensis, and found a total of 154 isoflavonoids isolated from their various tissues over the last three decades (1990–2021). The structural diversity, distributions, extraction and isolation protocols, and pharmacological properties of these isoflavonoids are all covered in this review.
Data extraction and methodology
Scientific search engines such as PubMed, Google Scholar, Web of Science, SciFinder, and Scopus were used to find and collect literature. In addition, some journal databases were searched, including Science Direct, Springer Link, and Wiley Online. Several search words and terms, including ‘isoflavonoids’, ‘Millettia’ (accompanied by species names including brandisiana, griffithii, extensa, dielsiana, dura, griffoniana, nitida, pachycarpa, and usaramensis), ‘phytochemistry’, ‘pharmacology’, ‘bioactivity’ and their combinations, were used to extract the target literature. Only articles written in English and published between January 1990 and December 2021 were kept, while preprints and unpublished papers were excluded.
Structural diversity of Millettia isoflavonoids
In the past three decades alone, at least 154 isoflavonoids have been isolated from the different tissues of these Millettia species. These include several classes and subclasses of isoflavonoids, including isoflavans, isoflavones (aglycones, methoxylated, prenylated, glycosylated, and geranylated), rotenoids, pterocarpans and coumaronochromenes. Table 1 summarizes the classes, names, and sources of these 154 isoflavonoids, and Figs. 2, 3, 4, 5, 6 and 7 show their structures. The scientific names of the isoflavonoids according to the International Union of Pure and Applied Chemistry (IUPAC) guidelines can be found in Supplementary Table S1.
Table 1.
List and class of isoflavonoids isolated from the different tissues of Millettia species
| Isoflavonoid class | Compound no | Compound name | Source | Collection country | References | |
|---|---|---|---|---|---|---|
| Millettia Species | Plant part | |||||
| Isoflavan | 1 | (3R)-Isovesitol | M. nitida | Vine stem | China | Liao et al. (2013) |
| 2 | (3R)-Vestitol | M. nitida | Vine stem | China | Liao et al. (2013) | |
| 3 | (3S)-Vestitol | M. dielsiana | Stem | Vietnam | Dat et al. (2019) | |
| Isoflavone (Aglycones) | 4 | Daidzein | M. nitida; M. dielsiana | Vine stem; stem | China, Vietnam | Liao et al. (2013); Gong et al. (2009) |
| 5 | Genistein | M. nitida, | Unspecified | China | Ye et al. (2012a, b) | |
| 6 | Prunetin | M. nitida | Vine stem | China | Liao et al. (2013) | |
| 7 | 2'-hydroxygenistein | M. nitida | Vine stem | China | Liao et al. (2013) | |
| 8 | Cladrastin | M. dielsiana | Stem | Vietnam | Gong et al. (2009) | |
| 9 | Formononetin | M. nitida | Vine stem | China | Liao et al. (2013) | |
| 10 | 7,3'-Dihydroxyl-5'-methoxyisoflavone | M. nitida; M. griffithii | Vine stem; stem | China |
Liao et al. (2013) Tang et al. (2016) |
|
| 11 | 7-Hydroxy-8,3',4'-trimethoxyisoflavone | M. usaramensis | Root bark | Kenya | Deyou et al. (2015) | |
| 12 | Robustigenin | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 13 | Olibergin A | M. brandisiana | Leaves | Thailand | Kikuchi et al. (2007) | |
| 14 | Afromosin | M. dielsiana | Stem | Vietnam | Gong et al. (2009) | |
| 15 | Maxamaisoflavone-D | M. dura | Seed pod | Kenya | Yenesewe et al. (1996) | |
| 16 | Maximaisoflavone-H | M. dura | Seed pod | Kenya | Yenesewe et al. (1996) | |
| 17 | Cuneatin methylether | M. griffoniana | Root bark | Cameroon | Yankep et al. (1997) | |
| 18 | Odorantin | M. griffoniana | Root bark | Cameroon | Yankep et al. (2003); Yankep et al. (1997) | |
| 19 | 8-Methylretusin | M. nitida; M. brandisiana | Whole plant; roots | China, Thailand | Ye et al. (2012a, b); Pailee et al. (2019) | |
| 20 | Calycosin | M. nitida | Whole plant | China | Ye et al. (2012a, b) | |
| 21 | Caviunin | M. dielsiana | Stem | Vietnam | Gong et al. (2009) | |
| 22 | Gliricidin | M. nitida | Whole plant | China | Ye et al. (2012a, b) | |
| 23 | 7,2′-Dimethoxy-4′,5′-methylenedioxyisoflavone | M. dura | Root barks | Kenya | Marco et al. (2017) | |
| 24 | 7-Hydroxy-2',4',5'-trimethoxyisoflavone | M. pachycarpa | Seeds | China | Tu et al. (2020) | |
| 25 | Maximaisoflavone G | M. griffoniana, M usaramensis | Root bark, Stem bark | Cameroon, Kenya | Yankeb et al. (2001); Yenesew eta. (1998) | |
| 26 | 7-Hydroxy-6-methoxy-3',4'-Methylenedioxyisoflavone | M. griffoniana | Root bark | Cameroon | Yankeb et al. (2001) | |
| 27 | 3'-Methylorobol | M. extensa, M. nitida | stems | Thailand, China | Raksat et al. (2018); Ye et al. (2012a, b) | |
| Isoflavones (Glycosylated) | 28 | Mildiside A | M. dielsiana | stem | Thailand | Kikuchi et al. (2007) |
| 29 | Ononin | M. dielsiana | stem | Thailand | Kikuchi et al. (2007) | |
| 30 | Dalpatin | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 31 | Odoratin-7-O-glucopyranoside | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 32 | Genistin | M. dielsiana, M. nitida | vine stems | China | Gong et al. (2014); Ye et al. (2012a, b) | |
| 33 | Glycitin | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 34 | Daidzin | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 35 | Wistin | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 36 | Hirsutissimiside A | M. nitida | Stem | China | Cheng et al. (2005) | |
| 37 | Hirsutissimiside C | M. nitida | Stem | China | Cheng et al. (2005) | |
| 38 | Hirsutissimiside B | M. nitida | Stem | China | Cheng et al. (2005) | |
| 39 | Sphaerobioside | M. nitida | Unspecified | China | Ye et al. (2012a, b) | |
| 40 | Formononetin-7-O-β-D-apiofuranosyl-(1, 6)–O-D-glucopyranoside | M. nitida | Unspecified | China | Ye et al. (2012a, b) | |
| 41 | Millesianin G | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 42 | Millesianin F | M. dielsiana | vine stems | China | Gong et al. (2014) | |
| 43 | Lanceolarin | M. nitida | Unspecified | China | Ye et al. (2012a, b) | |
| Isoflavones (Prenylated) | 44 | 5-Hydroxy-7-methoxy-4'-O-(3-methylbut-2-enyl)isoflavone | M. extensa | Stems, roots | Thailand | Raksat et al. (2018, 2019) |
| 45 | 5,7,5'-Trimethoxy-4'-O-prenylisoflavone | M. griffithii | stems | China | Tang et al. (2016) | |
| 46 | Brandisianin A | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 47 | 7,4'-Di-O-prenylgenistein | M. extensa; M. brandisiana | Stems, roots; Leaves |
Thailand Thailand |
Raksat et al. (2018, 2019); Pancharoen et al. (2008) | |
| 48 | Viridiflorin | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008); Kikuchi et al. (2007) | |
| 49 | Predurallone | M. dura | Seed pod | Kenya | Yenesewe et al. (1996) | |
| 50 | Furowanin B | M. pachycarpa | Leaves | Japan | Ito et al. (2006) | |
| 51 | Millesianin H | M. dielsiana | stems | China | Ye et al. (2014) | |
| 52 | Millesianin A | M. dielsiana | Vine stems | Vietnam | Gong et al. (2009) | |
| 53 | Millesianin I | M. dielsiana | stems | China | Ye et al. (2014) | |
| 54 | Brandisianin C | M. brandisiana | Leaves | Thailand | Kikuchi et al. (2007) | |
| 55 | Brandisianin E | M. brandisiana | Leaves | Thailand | Kikuchi et al. (2007) | |
| 56 | 6,8-Diprenyorobol | M. extensa; | roots | Thailand | Raksat et al. (2019) | |
| 57 | Millewanins G | M. pachycarpa | Leaves | Japan | Ito et al. (2006) | |
| 58 | Millewanins H | M. pachycarpa | Leaves | Japan | Ito et al. (2006) | |
| 59 | Griffonianone C | M. griffoniana | Root, stem; Root bark/seed pod | Camerroon | Wanda et al. (2006, 2007) | |
| 60 | Millexatin A | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 61 | Millipurone | M. extensa | Leaves | Thailand | Raksat et al. (2019) | |
| 62 | Millexatin B | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 63 | Millexatin C | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 64 | Millexatin D | M. extensa | Roots | Thailand | Raksat et al. (2019) | |
| 65 | Millexatin E | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 66 | Millexatin F | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 67 | Millexatin G | M. extensa | Leaves | Thailand | Raksat et al. (2019) | |
| 68 | Millexatin H | M. extensa | Leaves | Thailand | Raksat et al. (2019) | |
| 69 | Millexatin I | M. extensa | Roots | Thailand | Raksat et al. (2019) | |
| 70 | Millexatin J | M. extensa | Leaves | Thailand | Raksat et al. (2019) | |
| 71 | Millesianin B | M. dielsiana | Vine stems | Vietnam | Gong et al. (2009) | |
| 72 | Millesianin C | M. dielsiana | Vine stems | Vietnam | Gong et al. (2009) | |
| 73 | Millesianin D | M. dielsiana | Vine stems | Vietnam | Gong et al. (2009) | |
| 74 | Millesianin E | M. dielsiana | Vine stems | Vietnam | Gong et al. (2009) | |
| 75 | Ferrugone | M. dura | Seed pod | Kenya | Yenesew et al. (1997) | |
| 76 | Brandisianin D | M. brandisiana | Leaves | Thailand | Kikuchi et al. (2007) | |
| 77 | Auriculatin | M. extensa | Stems; leaves | Thailand | Raksat et al. (2018, 2019) | |
| 78 | Scandenone | M. extensa; M. pachycarpa | Roots, stems; seeds | Thailand, China | Raksat et al. (2018, 2019); Ye et al. (2012a, b) | |
| 79 | Auriculasin | M. extensa | Stems; leaves | Thailand | Raksat et al. (2018, 2019) | |
| 80 | Isoauriculasin | M. extensa | Roots, stems | Thailand | Raksat et al. (2018, 2019) | |
| 81 | Isoauroculatin | M. extensa | Stems, roots | Thailand | Raksat et al. (2018, 2019) | |
| 82 | 2'-deoxyisoauriculatin | M. extensa | Stems, roots | Thailand | Raksat et al. (2018, 2019) | |
| 83 | Durallone | M. dielsiana; M. dura | Stems; Seed pods | China, Kenya | Ye et al. (2014); Yenesewe et al. (1996) | |
| 84 | 6-Methoxycalpogonium isolfavone A | M. dielsiana; M. dura | Stems; seed pods | China, Kenya | Ye et al. (2014); Yenesew et al. (1997) | |
| 85 | Calopogoniumisolfavone A | M. dura; M. dielsiana | Seed pod; stems | Kenya, China | Yenesewe et al. (1996); Ye et al. (2014) | |
| 86 | 6-Demethyldurallone | M. dura | Seed pod | Kenya | Yenesewe et al. (1996) | |
| 87 | Hydroxy-6-methoxy-3–4-methylenedioxy-8–3-3-Dimethylallylisoflavone | M. dielsiana | stems | China | Ye et al. (2014) | |
| 88 | Elongatin | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 89 | 4'-Methylalpinumisofiauone | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 90 | 5-O-methyl-4'-O-(3-methyl-2-butenyl)alpinumisoflavone | M. extensa | Leaves | Thailand | Raksat et al. (2019) | |
| 91 | Barbigerone | M. pachycarpa, M. pachycarpa; M. usaramensis; M. dielsiana | Seeds; Stem bark; Stems | China, Kenya, Vietnam | Ye et al. (2010); Tu et al. (2019); Yenesew et al. (2003b); Ye et al. (2014); Gong et al. (2009) | |
| 92 | Isoerythrinin-A-4′-(3-methylbut-2-enyl) ether | M. dura | Seed pod; Root barks | Kenya | Yenesewe et al. (1996); Marco et., al. (2017) | |
| 93 | 2'-O-Methylisoauriculatin | M. extensa | stems | Thailand, | Raksat et al. (2018) | |
| 94 | Durmillone | M. griffoniana; M. dielsiana; M. dura | Root bark; Stems; Seed pod | Cameroon, China, Kenya | Yankep et al. (2003); Yankep et al. (1997); Ye et al. (2014); Yenesewe et al. (1996) | |
| 95 | Calopogoniumisoflavone B | M. griffoniana | Root barks | Cameroon, Kenya | Yankep et al. (1997); Marco et al. (2017) | |
| 96 | Jamaicin | M. usaramensis; M. dura; M. griffoniana | Root bark; Seed pods; root bark | Kenya, Cameroon | Deyou et al. (2015); Yenesew et al. (1997); Yankep et al. (1997) | |
| 97 | Ichthynone | M. dielsiana | Stems | China | Ye et al. (2014) | |
| 98 | 6'',6''-Dimethyl-5-hydroxy-3'-methoxy-4'-hydroxypyrano[2,'',3'':7,6]isoflavone | M. pachycarpa | Seeds | China | Ye et al. (2012a, b) | |
| 99 | 4',5'-Dimethoxy-6,6-dimethylpyranoisoflavone | M. pachycarpa | Seeds | China | Tu et al. (2019) | |
| 100 | 4'-Demethyltoxicarol isoflavone | M. brandisiana | leaves | Thailand | Kikuchi et al. (2009) | |
| 101 | Toxicarolisoflavone | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 102 | 6'',6''-Dimethyl-5-hydroxy-3',4'-dimethoxypyrano[2'',3'':7,6]isoflavone | M. pachycarpa | Seeds | China | Ye et al. (2012a, b) | |
| 103 | Milletenone A | M. pachycarpa | Seeds | China | Tu et al. (2019) | |
| 104 | cis-3'',4''-Dihydro-3'',4''-Dihydroxylonchocarpusone | M. Pachycarpa | Seeds | China | Tu et al. (2020) | |
| 105 | Griffonianone B | M. griffoniana | Root bark | Cameroon | Yankeb et al. (2001) | |
| 106 | Brandisianin B | M. brandisiana | Leaves | Thailand | Kikuchi et al. (2007) | |
| 107 | Milletenol A | M. Pachycarpa | Seeds | China | Tu et al. (2020) | |
| 108 | Norisojamaicin | M. usaramensis | Stem bark | Kenya | Yenesew et a. (1998) | |
| 109 | Maximaisoflavone B | M. dura | Root barks | Kenya | Marco et al. (2017) | |
| Isoflavones (Geranylated) | 110 | 7-O-Geranylformononetin | M. griffoniana | Root bark; seed pods | Cameroon | Yankep et al. (1997); Wanda et al. (2006) |
| 111 | 3',4'-Dihydroxy-7-O-[(E)-3,7-dimethyl-2,6-octadienyl]isoflavone | M. griffoniana | Root bark | Cameroon | Yankep et al. (1997) | |
| 112 | 7-O-Geranylpseudobaptigenin | M. griffoniana | Root bark | Cameroon | Yankep et al. (1997) | |
| 113 | Griffonianone D | M. griffoniana | Root bark | Cameroon | Yankep et al. (2003) | |
| 114 | 4'-O-Geranylisoliquiritigenin | M. griffoniana | Root bark/seed pod | Cameroon | Wanda et al. (2006) | |
| 115 | 4'-Methoxy-7-O-[(E)-3-methyl-7-hydroxymethyl-2,6-octadienyl]isoflavone | M. griffoniana | Root bark/seed pod | Cameroon | Wanda et al. (2006) | |
| Rotenoids | 116 | 12a-Hydroxyrotenone | M. pachycarpa; M. brandisiana | Seeds; Roots | China, Thailand | Tu et al. (2019); Pailee et al. (2019) |
| 117 | Villosinol | M. brandisiana | Roots | Thailand | Pailee et al. (2019) | |
| 118 | Tephrosin | M. brandisiana; M. dura; M. pachycarpa; M. usaramensis | Roots; seed pods, seeds; seeds; Root bark | Thailand, Kenya, China | Pailee et al. (2019); Yenesew et al. (1997, 2003b); Tu et al. (2019); Ye et al. (2008; 2012a, b); Deyou et al. (2015) | |
| 119 | α-Toxicarol | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 120 | 12a-Hydroxy-α-toxicarol | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 121 | 6a,12a-Dehydro-α–toxicarol | M. brandisiana; M. extensa | Leaves; stems | Thailand | Pancharoen et al. (2008); Raksat et al., 2018 | |
| 122 | 6-Hydroxy-6a,12a-dehydro-α -toxicarol | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 123 | 6a,12a-Dehydrosermundone | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 124 | Stemonal | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 125 | Sermundone | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 126 | 6-Deoxyclitoriacetal | M. brandisiana | Leaves | Thailand | Pancharoen et al. (2008) | |
| 127 | Deguelin | M. dura, M. pachycarpa | Seeds | Kenya, China | Yenesew et al. (2003a); Tu et al. (2019); Ye et al. (2008; 2012a, b) | |
| 128 | Millettone | M. dura | Seed pod | Kenya | Yenesew et al. (1997) | |
| 129 | Millettosin | M. dura; M. usaramensis | Seed pod; Root bark | Kenya, China | Yenesew et al. (1996); Deyou et al. (2015) | |
| 130 | Rotenone | M. dura | Seeds | Kenya | Yenesew et al. (2003a) | |
| 131 | Sumatrol | M. extensa | stems | Thailand | Raksat et al. (2018) | |
| 132 | Usararotenoid A | M. usaramensis | Root bark; Stem bark | Deyou et al. (2015); Yenesew et al. (2003b) | ||
| 133 | Usararotenoid C | M. usaramensis | Root bark; Stem bark | Kenya | Deyou et al. (2015); Yenesew et al. (2003b) | |
| 134 | 12-Dihydrousararotenoid A | M. usaramensis | Root bark | Kenya | Deyou et al. (2015) | |
| 135 | 12-Dihydrousararotenoid B | M. usaramensis | Root bark | Kenya | Deyou et al. (2015) | |
| 136 | 13-Homo13-oxa-6a,12a-dehydrodeguelin | M. pachycarpa | Seeds | China | Ye et al. (2010, 2012a, b) | |
| 137 | 6a,12a-Dehydrodeguelin | M. pachycarpa | Seeds | China | Ye et al. (2008, 2012a, b) | |
| 138 | 6a,12a-Dehydromillettone | M. usaramensis | Stem bark | Kenya | Yenesew et al. (2003b) | |
| 139 | 12α-Hydroxy-12-dihydro-( +)-usararotenoid-A | M. usaramensis | Stem bark | Kenya | Yenesew et al. (1998) | |
| 140 | 12-Dihydrousararotenoid C | M. usaramensis | Root bark | Kenya | Deyou et al. (2015) | |
| 141 | Epimilletosine | M. usaramensis | Root bark; Stem bark | Kenya | Deyou et al. (2015); Yenesew et al. (2003b) | |
| 142 | trans-4',5'-Dihydro-4',5'-dihydroxytephrosin | M. pachycarpa | Seeds | China | Tu et al. (2020) | |
| 143 | ( +)-Usararotenoid B | M. usaramensis | Stem bark | Kenya | Yenesew et al. (1998) | |
| 144 | Griffonianone A | M. griffoniana | Root bark | Cameroon | Yankeb et al. (2001) | |
| 145 | cis-4',5'-Dihydro-4',5'-dihydroxytephrosin | M. pachycarpa | Seeds | China | Tu et al. (2020) | |
| Coumarin | 146 | 4-Hydroxy-5,6,7-trimethoxy-3-(3',4'-Methylenedioxy)phenylcoumarin | M. griffoniana | Root bark | Cameroon | Yankeb (1998) |
| Pterocarpans | 147 | Brandisianin F | M. brandisiana | Leaves | Thailand | Kikuchi et al. (2007) |
| 148 | (-)-Medicarpin | M. brandisiana | Roots | Thailand | Pailee et al. (2019) | |
| 149 | (-)-Maackiain | M. brandisiana; M. extensa; M. nitida | Roots; stems | Thailand, China | Pailee et al. (2019; 2019); Ye et al. (2012a, b) | |
| 150 | Erycristagallin | M. extensa | Leaves | Thailand | Raksat et al. (2019) | |
| 151 | 3-O-Prenylmaackiain | M. dura | Root barks | Kenya | Marco et al. (2017) | |
| Chromanochromenes | 152 | Millexatin K | M. extensa | Roots | Thailand | Raksat et al. (2019) |
| 153 | Millexatin L | M. extensa | Roots | Thailand | Raksat et al. (2019) | |
| 154 | Millexatin M | M. extensa | Roots | Thailand | Raksat et al. (2019) | |
Fig. 2.
Chemical structures of isoflavans (1–3) and aglycone isoflavones (4–27) isolated from Millettia species
Fig. 3.
Glycosylated isoflavonoids isolated from Millettia species
Fig. 4.
Prenylated isoflavonoids isolated from Millettia species
Fig. 5.
Geranyl isoflavonoids isolated from Millettia species
Fig. 6.
Rotenoids isolated from Millettia species
Fig. 7.
Coumarin (146), pterocarpans (147–151) and coumaronochromenes (152–154) isolated from Millettia species
Isoflavans
Isoflavans are characterized by the absence of C = C and/or C = O bonds at the C-ring. Three isoflavans, (3R)-isovesitol (1), (R)-vestitol (2), and (S)-vestitol (3), have been isolated thus far, signifying the rarity of these classes of isoflavonoids in the Millettia species (Dat et al. 2019; Liao et al. 2013). Interestingly, (R)-vestitol and (S)-vestitol are enantiomers of each other and were isolated from the stems of two different species (M. nitida and M. dielsiana, respectively) (Fig. 2, Table 1). Brazilian red propolis, a resinous material produced by honeybees, has recently been identified as an excellent source of vestitol and isovestitol. Several studies established the botanical origin of this material to be Dalbergia ecatosphyllum, a species in the legume family (Bueno-Silva et al. 2013; Franchin et al. 2016). As a result, some Millettia species may serve as alternative sources of these molecules. Furthermore, due to their diverse pharmacological activities, both (R)-vestitol and (S)-vestitol are synthetically targeted (Ciesielski & Metz 2020; Luniwal and Erhardt 2011; Yalamanchili et al. 2018). Despite these signs of progress, studies on the relative pharmacological activities of these molecules are scarce, which could provide a research opportunity.
Isoflavones
Isoflavones, as opposed to isoflavans, have both C = C and C = O bonds at the C-ring and are the most diverse class of isoflavonoids isolated from these Millettia species. A total of 112 isoflavones were reported, with 24 being aglycones (4–27), 16 being glycosylated (28–43), 66 being prenylated (44–109), and the remaining 6 being geranylated (110–115) isoflavones.
Aglycone isoflavones
As previously stated, 24 aglycones (4–27) were reported from these Millettia species. Except for M. extensa and M. pachycarpa, each of the other species had at least two aglycone isoflavones isolated from their different tissues, indicating their abundance. Among the various tissues of these Millettia species, the greatest number of aglycones were isolated from the stem parts (Table 1). With the exceptions of daidzein (4), genistein (5), and 2'-hydroxygenistein (7), the remaining aglycones were either mono- (9 compounds), di- (6 compounds) or poly- (6 compounds) methoxylated. Figure 2 also demonstrates the structural diversity of aglycone isoflavones, and one can easily observe that methylation can occur at several positions, including 5, 6, 7, and 8 (A-ring) and 2', 3', 4', 5' and 6' (B-ring) of Millettia isoflavones. In addition, some of these molecules, such as 15–18, 23, 25, and 26, contain an additional methylenedioxy substituent, which adds to their structural diversity. In general, methylation of flavonoids is thought to increase their bioavailability and chemopreventive effects (Walle 2009). As a result of these discoveries, the laboratory synthesis of naturally occurring methoxylated isoflavones, including those isolated from Millettia species, has become a research priority intending to study structure–activity relationships (SARs). For example, formononetin (9), the simplest of all methoxylated isoflavones, is synthetically known and has been used as a substrate to synthesize several analog derivatives (Mutai et al. 2015). Recently, Tay et al. (2019) published a review that revealed formononetin’s diverse pharmacological activities, including anticancer properties. Similarly, the synthesis and pharmacological potentials of other aglycone isoflavones, such as genistein (5), prunetin (6), and robustigenin (12), have been reported (Li et al. 2006; Nakayama et al. 1980). Despite these successes, methylation of positions 5 and 6' and hence the laboratory synthesis of their derivatives remains a challenge. This is due in part to the energy barrier of such molecules as a result of their stability, as well as the possibility of chelation of these positions to the carbonyl oxygen at the C-ring (Dixon 19,993). In this regard, the isolation of cuneatin methylether (17), a 5-methoxy isoflavone, and odoratin (19), a 6'-methoxy isoflavone, from the root bark of M. griffoniana could open up a new range of possibilities for studying the enzymatic synthesis of such molecules for SAR studies (Chebil et al. 2006; Yankep et al. 1997; 2003). Furthermore, a 5-O-methyltransferase enzyme responsible for the biosynthesis of such classes of isoflavonoids in other legumes, such as lupin, was purified (Khouri et al. 1988). This could open up new avenues for research into the specific candidate genes responsible for the biosynthesis of such isoflavonoids in Millettia species.
Glycosylated isoflavones
Glycosylated isoflavones contain one or more sugar units in their structure. A total of 16 glycosylated isoflavones (28–43) were reported from these Millettia species (Fig. 3). Structurally, position 7 was found to be the glycosylation site in all of the molecules except for mildiside A (28) and hirsutissimiside C (37), which were glycosylated at positions 4' and 8, respectively. Apiosyalted molecules (40–43), one of the synthetically rare glycosylated isoflavones, were also reported (Gong et al. 2014; Ye et al. 2012a, b). Among all the Millettia species, the stems of M. dielsiana and M. nitida were found to be rich sources of glycosylated isoflavones (Table 1). Genistin (32), a chemoprotective isoflavone abundant in soybeans together with glycitin (33) and daidzin (34), was also isolated from the stem vines of these two species (Gong et al. 2014; Ye et al. 2012a, b). Glycosylation is one of the most important factors considered in modifying the solubility, bioavailability, and therapeutic potential of bioactive molecules of synthetic and natural origin (Hanh et al. 2020; Szeja et al. 2017). As a result, the synthesis of glycosylated isoflavones has long been a research focus (Szeja et al. 2017). In this regard, attempts have been made to synthesize many of the glycosylated isoflavones isolated from Millettia species, including dalpatin (30), a 5'-methoxylated molecule, although some are inefficient for commercialization (Lewis et al. 1998). To the best of our knowledge, efficient laboratory synthesis protocols for hirsutissimisides A-C (36–38) and millesianins F-G (41, 42) have yet to be reported.
Prenylated isoflavones
A prenyl structure denotes the 3,3-dimethyl allyl unit, and isoflavones containing one or more of this substituent are known as prenylated isoflavones (Santos and Silva 2020; Simons et al. 2012). These classes of isoflavones are the most diverse classes of isoflavones found in the Millettia species and were isolated from the leaves, stems, roots, and seed parts (Fig. 4, Table 1). Among these plant tissues, the maximum number of prenylated isoflavones was isolated from the stems, followed by leaves. They were also structurally diverse. Among the 66 prenylated isoflavones (44–109) reported from the different tissues of these species, 41 molecules were mono-prenylated, and 23 were di-prenylated (Fig. 4). In addition, two tri-prenylated isoflavones, millexatin A (60) and millipurone (61), were isolated from the leaves of M. extensa. Such tri-prenylated isoflavonoids have also rarely been reported in other legumes (Veitch 2013). The prenyl group can also be linear or cyclic (such as pyran or furan), and it can be O-prenylated or C-prenylated. In this regard, positions 4´, 6, 7, and 8 were found to be potential prenylation sites. Furthermore, many of the prenylated molecules are methoxylated, proving the structural diversity and complexity of Millettia isoflavones. Such structural diversity could provide an excellent opportunity for SAR research (Kalli et al. 2021). Prenylation is thought to increase the lipophilic nature of organic molecules, which improves their affinity toward protein interactions in biological membranes (Botta et al. 2009; Simons et al. 2012; Veitch 2013). Because of these factors, several naturally occurring prenylated isoflavones have been synthesized (Mukne et al. 2011). It is worth noting that some of the prenylated isoflavonoids from Millettia species, including the newly discovered milletenone A (103), are synthetically unknown and have received little attention in SAR research (Tu et al. 2019). As a result, such molecules could provide a great research opportunity and a clue to the enzymatic synthesis of prenylated isoflavones in laboratories (Mora-Pele et al. 2013).
Geranylated isoflavones
Geranylated isoflavones contain a C10-isoprenoid substituent called geranyl ([E]-3, 7-dimethyl-2,6-octadienyl unit). The pyrophosphate derivative of this substituent is an intermediate in the phenylpropanoid pathway, and its bioavailability heavily influences the distribution of geranylated isoflavones in plants. In comparison to the aforementioned classes of isoflavones, geranylated isoflavones were rarely observed in these Millettia species, with only six isolated. Structurally, all were exclusively 7-O-geranylated (Fig. 5) and derived from the root bark or seed pods of M. griffoniana (Wanda et al. 2006; Yankep et al. 1997, 2003). This is unlike Caragan pruinosa, another legume species known for C-geranlylated isoflavonoids (Al-Maharik 2019). There are also other legume species, such as those in the genus Campylotropis, where C-geranylated isoflavones are widely distributed (Al-Maharik 2019; Felpin et al. 2007; Sun et al. 2015). Several geranylated isoflavones have been synthesized. For example, the synthesis of 7-O-geranylformonentin (110) and its dihydroxylation product, Griffonianone D (113), has been reported, demonstrating the importance of Millettia isoflavones in drug discovery (Felpin et al. 2007; Selepe and Heerden 2013). However, the pharmacological properties of many of these isoflavonoids have rarely been investigated, and this could be a promising future research area.
Rotenoids
Rotenoids are another class of isoflavonoids widely distributed in Millettia species. A total of 30 structurally diverse rotenoids (116–145) were isolated in these Millettia species alone and are widely distributed across the different tissues of these species, including leaf, stem, root and seed parts (Table 1). Millettia species’ rotenoids are structurally diverse, containing methoxy, prenyl, or methylenedioxy substituents, and two or more of these groups in their structures (Fig. 6). Tephrosin (118) is the most abundant rotenoid in the Millettia species and was isolated from M. brandisiana roots, M. dura seeds and seed pods, M. pachycarpa seeds and seed pods, and M. usaramensis root bark (Deyou et al. 2015; Pailee et al. 2019; Tu et al. 2019; Ye et al. 2012a, b; Yenesew et al. 1997, 2003a, 2003b). This molecule is also synthetically known, having been used as a lead molecule in the synthesis of several analogs and having been reported to have a variety of pharmacological properties, making it ideal for structural modification and SAR analysis (Xu et al. 2018). Another popular rotenoid, rotenone (130), was isolated from the seeds of M. dura. Synthetically, it is used as a precursor in the preparation of villosinol (117) (Russell et al. 2018). Likewise, sumatrol (131) and deguelin (127) are popular rotenoids that have been used in the synthesis of pharmacologically active analogs (Russell et al. 2018; Xu et al. 2018). Interestingly, millettosine (129) and epimilletosine (141) are synthetically known diasteriomers isolated from root barks of M. usaramensis (Deyou et al. 2015; Perveen et al. 2019; Yenesew et al. 2003b). The former was also isolated from M. dura seeds, while the latter was isolated from M. usaramensis stem bark (Deyou et al. 2015; Yenesew et al. 1996). A structurally unique rotenoid, 13-homo13–oxa-6a,12a-dehydrodeguelin (136), was also isolated from the seeds of M. pachycarpa (Ye et al. 2012a, b, 2010). In general, Millettia rotenoids are structurally diverse, which could lead to exciting multidisciplinary research opportunities in the future.
Phenylcoumarins
Coumarins, also known as 1, 2-benzopyrones, are another important class of isoflavonoids and are widely distributed in fruits such as cherries and berries (Kumar et al. 2021; Wu et al. 2009). The only phenylcoumarin isolated from the Millettia species considered in this review was 4-hydroxy-5, 6, 7-trimethoxy-3-(3',4'-methylenedioxy)phenylcoumarin (146) (Fig. 7). The molecule was isolated from the root bark of M. griffoniana (Yankeb et al. 1998), and the discovery could point to the rarity of such subclasses of isoflavonoids in Millettia species.
Pterocarpans
This review discovered only five pterocarpans (147–151) reported from the nine species considered to signify their rarity in the genus Millettia (Fig. 7). This is in contrast to other genera in the legume family, such as Erythrina, which are known for having a high concentration of such isoflavonoids in their tissues (Fahmy et al. 2018). Maackiain (149) was isolated from M. brandisiana and M. extensa roots, as well as M. nitida stems (Pailee et al. 2019; Raksat et al. 2018; Ye et al. 2012a, b). On the other hand, (-)-medicarpin (148) and brandisianin F (147) were isolated from the leaves and roots of M. brandisiana, whereas erycristagallin (150) and 3-O-prenylmaackiain (151) were isolated from M. extensa leaves and M. duara root bark, respectively (Kikuchi et al. 2007; Marco et al. 2017; Pailee ete al. 2019; Raksat et al. 2019). Natural pterocarpans such as (-)-maackiain (149) and (-)-medicarpin (148) have been synthetically targeted (Feng et al. 2015; Goel et al. 2013; Ozaki et al. 1989; Yang et al. 2017). The laboratory synthesis of other Millettia pterocrapans, such as eryrcristagalin (150), a di-prenylated pterocrapan, could be of great interest.
Coumaronochromenes
Coumaronochromenes are also uncommon in Millettia species (Fig. 7). This review also found only three molecules: millexatin K (152), millexatin L (153), and millexatin M (154). All of these molecules were isolated from M. extensa roots (Raksat et al. 2019). A targeted investigation of other tissues of the plant or species could provide detailed information about the diversity of coumaronochromenes in Millettia species.
Extraction and isolation of isoflavonoids from Millettia species
The choice of an ideal solvent system, as well as appropriate extraction and isolation techniques, are important factors in determining the efficiency of plant metabolite extraction and isolation (Ivanovic et al. 2020). Because isoflavonoids are polar molecules, they are typically extracted with pure or mixtures of polar organic solvents. Many studies conducted on Millettia species also used polar solvents such as ethanol, methanol, chloroform, dichloromethane, acetone, and ethyl acetate (Table 2). Furthermore, liquid–liquid extraction procedures were also used to obtain a variety of extracts with varying polarities. Among all the solvents, the most widely used solvent system was 95% ethanol, followed by dichloromethane and chloroform. In a rare case, Yankeb et al. (1997) isolated geranylated (110, 112) and prenylated (95) isoflavones from hexane-crude extracts of M. griffoniana root bark. Except for a few studies, direct extraction of the plant parts was conducted without a predefatting step (Yankep 2003). This indicates that isoflavonoid-rich extracts can be obtained from Millettia species without the need for an additional defatting step.
Table 2.
Common solvents and extraction methods used to obtain isoflavonoid-rich extracts from Millettia species
| Solvent used/Extraction condition | Isolation method | Class of isoflavonoid | References |
|---|---|---|---|
| Methanol/RT | RP-HPLC | Prenylated isoflavones (46, 54, 106) | Kikuchi et al. (2007) |
| Ethanol/RT | RP-HPLC | Prenylated isoflavones (91, 78, 102, 98); Rotenoid (136) | Ye et al. (2012a) |
| CCC | Rotenoid (127, 118, 137); Prenylated isoflavone (99) | Ye et al. (2012a) | |
| CC, VLC, P-TLC | Aglycone isoflavones (12); Prenylated isoflavones (46, 47, 101, 48); Rotenoid (119–126) | Pancharoen et al. (2008) | |
| 95% Ethanol/RT | Silica gel packed CC | Isoflavan (3) | Dat et al. (2019) |
| Aglycone isoflavones (9) | Dat et al. (2019) | ||
| Glycosylated isoflavones (28, 29, 37, 40) | Cheng et al. (2005); Dat et al. (2019) | ||
| Prenylated isoflavones (53, 91, 94, 84, 85, 87, 72) | Ye et al. (2014)* | ||
| Sephadex LH-20 packed CC | Glycosylated isoflavones (36, 37) | Cheng et al. (2005) | |
| Aglycone isoflavone (10) | Tang et al. (2016) | ||
| CCC/HSCCC | Prenylated isoflavones (45,45, 83, 97, 99, 73) Rotenoid (127, 118,137) | Ye et al. (2014)*; Ye et al (2012a); Tang et al. (2016)*; Ye et al. (2008; 2012a) | |
| SemiP-HPLC | Prenylated isoflavone (91); Rotenoid (136) |
Ye et al. (2010) Ye et al. (2010) |
|
| 95% Ethanol/Reflux | P-HPLC | Prenylated isoflavones (52) | Gong et al. (2009) |
| ODS-CC | Aglycone isoflavone (21) | ||
| Silica gel-CC | Prenylated isoflavones (72–74); Aglycone isoflavones (14, 8, 4) | ||
| HSCCC | Rotenoids (118, 127, 137); Prenylated isoflavones (99) | Ye te al. (2008) | |
| Sephadex LH-20 CC and P-HPLC |
Aglycone isoflavone (4–6) Isoflavan (3) |
Liao et al. (2013) | |
| P-HPLC | Aglycone isoflavone (9) | Liao et al. (2013) | |
| P-HPLC | Glycosylated isoflavones (30–35, 41, 42) | Gong et al. (2014) | |
| Sephadex LH-20 CC | Glycosylated isoflavone (35) | ||
| 95% Ethanol/Ultrasonic bath, RT | Toyopearlgel HW-40F CC |
Prenylated isoflavone (99, 103) Rotenoids (118, 127, 116) |
Tu et al. (2019)* |
| P-TLC | Prenylated isoflavone (107, 104) | Tu et al. (2020) | |
| Rotenoids (142, 145) | Tu et al. (2020) | ||
| Toyopearl gel HW-40F column chromatography | Aglycone isoflavone (24) | Tu et al. (2020) | |
| P-HPLC | Prenylated isoflavone (55, 107, 104); Rotenoid (116–118); Pterocarpans (147–149) | Tu et al. (2020) | |
| CHCl3/cold percolation | Silica-CC | Prenylated isoflavone (49, 75, 83–86, 92, 94–96); Aglycone isoflavone (9, 15,16); Rotenoids (127–129, 118, 137, 128, 118) | Yenesew et al. (1997); Yenesew et al. (2003b); Yenesew et al. (1996) |
| Chloroform/RT (defatted with hexane) | VLC-silica gel | Prenylated isoflavone (94); Aglycone isoflavone (18) | Yankeb et al. (2003) |
| Sephadex LH-20 CC | Geranylated isoflavone (113) | Yankeb et al. (2003) | |
| VLC-silica gel and P-TLC | Aglycone isoflavone (18, 23); Prenylated isoflavone (94, 96) | Yankeb et al. (1997) | |
| Silica gel-CC | Prenylated isoflavone (59); Geranylated isoflavone (114, 112, 111, 115) | Wanda et al. (2006) | |
| Silica-CC, Prep-TLC | Geranylated isoflavone (115, 111); Coumarins (146) | Yankeb et al. (1998) | |
| Silica-CC, Prep-TLC | Rotenoids (144); Prenylated isoflavones (59, 105); Aglycone isoflavone (26) | Yankeb et al. (2001) | |
| P-TLC | Prenylated isoflavones (91) | Tu et al. (2019)* | |
| Dichloromethane | Silica-CC | Rotenoids (132, 133, 141, 138); Prenylated isoflavones (91); Geranylated isoflavones (114) | Yenesew et al. (2003b) |
| Sephadex-LH-20 CC | Prenylated isoflavone (108, 96, 91); Aglycone isoflavone (25) | Yenesew et al. (1998) | |
| Dichloromethane/RT | P-HPLC | Aglycone isoflavone (19) | Pailee et al. (2019) |
| CH2Cl2/MeOH (1:1), | CC-silica gel | Rotenoids (118, 135, 133, 129); Aglycone isoflavones (16) | Deyou et al. (2015) |
| Sephadex LH-20 | Rotenoids (132, 134, 140); Aglycone isoflavones (16) | ||
| RP-HPLC | Rotenoid (141, 133, 118) | ||
| P-TLC | Aglycone isoflavone (11) | ||
| Dichloromethane/methanol (1:1 v/v)/cold percolation | CC-silica gel | Prenylated isoflavone (83–85, 96, 94, 97); Aglycone isoflavone (9) | Buyinza et al. (2021) |
| CH2Cl2/CH3OH (1:1), | CC on Sephadex LH-20; preparative HPLC | Pterocarpans (151) | Marco et al. (2017) |
| Silica gel-CC | Prenylated isoflavone (95, 109, 92) | ||
| RP-HPLC | Prenylated isoflavone (94) | ||
| CC on silica gel | Aglycone isoflavones (23, 11) | ||
|
Acetone/RT Acetone/RT |
Silica gel-CC | Prenylated isoflavone (44, 47, 56, 60–66, 77, 78, 79, 88, 93, 80, 81, 89); Aglycone isoflavones (27); Rotenoid (121); Pterocarpans (149) | Raksat et al. (2018) |
| Silica-CC, P-TLC | Prenylated isoflavone (50, 57, 58) | Ito et al. (2006) | |
| EtOAc by cold percolation | Silica-CC | Rotenoids (132, 143) | Yenesew et al. (1998) |
| Ethyl acetate | Silica gel-CC | Prenylated isoflavones (44, 47, 60–62, 64, 66–70, 78, 80–82, 90); Chromanochromenes (152–154); Pterocarpans (150) | Raksat et al. (2019) |
| n-hexane/RT | VLC-silica gel, CC and P-TLC | Geranylated isoflavones (110, 112); Prenylated isoflavones (95) | Yankeb et al. (1997) |
*Bioassay-guided isolations/fractionations
During extraction, maceration at room temperature was the most widely used technique (Cheng et al. 2005; Dat et al. 2019; Kikuchi et al. 2007; Pancharoen et al. 2008; Tang et al. 2016; Ye et al. 2010, 2012a). Other techniques, such as reflux, sonication, and cold percolation, were also used to obtain isoflavonoid-rich crude extracts (Table 2). For the isolation of individual molecules, the thin-layer chromatography (TLC)-guided column chromatography (CC) technique was mostly used, and components were eluted using mixtures of both polar and nonpolar organic solvents. Silica-gel packed CC was the most popular isolation technique, which may be due to its low cost and ease of application. Moreover, there were occasions where resins such as Sephadex LH-20 and Toyopearlgel HW-40F were used in place of silica gel (Cheng et al. 2005; Gong et al. 2014; Liao et al. 2013; Tu et al. 2020). Individual isoflavonoids have also been isolated using other techniques, such as countercurrent chromatography (CCC), high-speed countercurrent chromatography (HSCCC), and vacuum liquid chromatography (VLC) (Pancharoen et al. 2008; Tang et al. 2016; Ye et al. 2014, 2008, 2012a). Preparative high-performance liquid chromatography (P-HPLC) was another popular isolation technique used to isolate individual isoflavonoids. P-HPLC is more efficient than column chromatography methods and can isolate even small amounts of metabolites from bulk matrices (Deyou et al. 2015; Gong et al. 2009, 2014; Marco et al. 2017; Tu et al. 2020). Many of the studies combined two or more of the aforementioned isolation techniques, either in a bioassay-guided or untargeted isolation of Millettia isoflavonoids (Liao et al. 2013; Marco et al. 2017; Pancharoen et al. 2008; Ye et al. 2014; Tang et al. 2016). In general, our findings indicated that no single extraction technique or solvent system was applied to extract or isolate a specific class of isoflavonoids in Millettia species. Future studies on Millettia species could benefit from the use of more efficient and recently developed extraction and isolation techniques, such as supercritical fluid extraction, microwave-assisted extraction, pressurized liquid extraction, and enzyme-assisted extraction (Fitzgerald et al. 2020; Ivanovic et al. 2020).
Structural characterization techniques
The structural characterizations of isoflavonoids isolated from the various tissues of Millettia species include determining molecular weight, chromophore structure, and substituents. Several chromatographic and spectrometric techniques, including high-performance liquid chromatography (HPLC), one-dimensional (1H-NMR and 13C-NMR) and two-dimensional (COSY, HMBC, and HSQC) nuclear magnetic resonance spectroscopy (NMR), mass spectrometry (MS), infrared spectroscopy (IR), and ultraviolet–visible spectroscopy (UV–Vis), have been used to achieve these goals (Dat et al. 2019; Tang et al. 2016; Tu et al. 2019; Yankeb et al. 2001). Nonspectrometric techniques such as X-ray crystallography, circular dichroism (CD) and computational methods have also been used to help determine chiral center configurations (Liao et al. 2013; Marco et al. 2017; Pailee et al. 2019). Because of their sensitivity and application in complex mixtures, hyphenated techniques such as LC–MS/MS, LC-NMR, and LC–MS-NMR have recently gained popularity for the structural analysis of plant metabolites (Gathungu et al., 2020). As a result, the use of such techniques in future studies could aid in the identification of more Millettia isoflavonoids, as well as their isolation and pharmacological investigation.
Pharmacological activities of Millettia isoflavonoids
The chemical structure of isoflavonoids influences their pharmacokinetic properties, which in turn determines their bioavailability and biological activities (Vitale et al. 2012). Numerous studies have been conducted to investigate the pharmacological properties of Millettia isoflavonoids. Owing to their structural diversity, several disease-protecting properties, including antibacterial, anti-inflammatory, anticancer, and estrogenic activities, among others, have been reported. The sections that follow summarize the pharmacological properties of Millettia isoflavonoids. Table 3 summarizes the active compounds and their biological activities, as well as their concentration giving 50% inhibition (IC50) and/or minimum inhibitory concentration (MIC).
Table 3.
Biological activities of isoflavonoids isolated from Millettia species
| Biological activity | Compound name | Assay/Model | Effect (MIC, IC50) | Reference |
|---|---|---|---|---|
| Anti-inflammatory activity | Scandenone | RAW264.7 Macrophages | Inhibition of NO-production (IC50: 8.5 µM) | Raksat et al. (2019) |
| 6,8-Diprenyorobol | RAW264.7 Macrophages | Inhibition of NO-production (IC50: 14.3 µM) | Raksat et al. (2019) | |
| Brandisianin A | RAW264.7 Macrophages | Inhibition of NO-production (IC50: 35.7 µM) | Tang et al. (2016) | |
| Griffoninaone D | PLA2 and TPA-induced mouse ear Edema (Female Wistar rat) | Inhibition of swelling (0.25 mg/ear, 5 mg/kg) | Yankep et al. (2003) | |
| (3S)-vestitol | RAW264.7 Macrophages | Inhibition of NO-production (IC50: 16.0 µM) | Dat et al. (2019) | |
| 6-Deoxyclitoriacetal | Male Sprague–Dawley rats | inhibited the ear edema formation (1 mg/ear) | Pancharoen et al. (2008) | |
| α-Toxicarol | Male Sprague–Dawley rats | inhibited the ear edema formation (1 mg/ear) | Pancharoen et al. (2008) | |
| cis-3'',4''-Dihydro-3'',4''-Dihydroxylonchocarpusone | RAW264.7 macrophages | Dose dependent inhibition of NO-production | Tu et al. (2020) | |
| Milletenol A | RAW264.7 macrophages | Dose dependent inhibition of NO-production | Tu et al. (2020) | |
| Anticancer activity | Griffonianone C | MCF-7 cells | Upregulation of mRNA expression of Ki-67 (10–8 M) and CD1 (10–7 M) | Wanda et al. (2006) |
| Usararotenoid A | MDB-MB-231 cancer Cells | Cytotoxic (IC50: 87.3 µM) | Deyou et al. (2015) | |
| Millettosin | MDB-MB-231 cancer Cells | Cytotoxic to (IC50: 61.7 µM) | Deyou et al. (2015) | |
| 12a-Epimillettosin | MDB-MB-231 cancer Cells | Cytotoxic (IC50: 100.7 µM) | Deyou et al. (2015) | |
| Usararotenoid C | MDB-MB-231 cancer Cells | Cytotoxic (IC50: 25.7 µM) | Deyou et al. (2015) | |
| 4'-O-geranylisoliquiritigenin | MDB-MB-231 cancer Cells | Cytotoxic (IC50: 125.5 µM) | Deyou et al. (2015) | |
| Brandisianin B | HeLa cancer Cells | Cytotoxic (IC50: 9.7 µM) | Kikuchi et al. (2007) | |
| Brandisianin C | HeLa cancer Cells | Cytotoxic (IC50: 19.1 µM) | Kikuchi et al. (2007) | |
| Brandisianin E | HeLa cancer Cells | Cytotoxic (IC50: 21.7 µM) | Kikuchi et al. (2007) | |
| Barbigerone | HepG2, C26, LL2 B16 cancer cell lines | Induction of aptosis (HepG2 (IC50: 0.61 µM), C26 (IC50: 7.81 µM), LL2 (IC50: 0.36 µM), and B16 (IC50: 5.47 µM) | Ye et al. (2012a, b) | |
| Deguelin | HepG2, C26, LL2, B16 cancer cell lines | Induction of aptosis (HepG2 (IC50: 1.55 µM), C26 (IC50: 8.93 µM), LL2 (IC50: 0.51 µM), and B16 (IC50: 0.20 µM) | Ye et al. (2012a, b) | |
| 3-Homo13-oxa-6a,12a-dehydrodeguelin | HepG2, C26, LL2, B16 cancer cell lines | Induction of aptosis (HepG2 (IC50: 17.48 µM), C26 (IC50: 10.10 µM), LL2 (IC50: 3.33 µM), and B16 (IC50: 10.15 µM) | Ye et al. (2012a, b) | |
| Tephrosin | HepG2, C26, LL2, B16 cancer cell lines | Induction of aptosis (HepG2 (IC50: 1.41 µM), C26 (IC50: 6.49 µM), LL2 (IC50: 0.56 µM), and B16 (IC500: 15.95 µM) | Ye et al. (2012a, b) | |
| 6a,12a-dehydrodeguelin | HepG2, C26, LL2, B16 cancer cell lines | Induction of aptosis (HepG2 (IC50: 2.93 µM), C26 (IC50: 7.55 µM), LL2 (IC50: 1.35 µM), and B16 (IC50: 8.85 µM) | Ye et al. (2012a, b) | |
| Maximaisoflavone B | MDA-MB-231 breast cancer cells | Cytotoxic (IC50: 153.5 µM) | Marco et al. (2017) | |
| 7,2′-Dimethoxy-4′,5′-dimethylenedioxy isoflavone | MDA-MB-231 breast cancer cells | Cytotoxic (IC50: 174.1 µM) | Marco et al. (2017) | |
| Durmillone | A549 cancer cell line | Cytotoxic (IC50: 6.6 ± 1.2 mM) | Buyinza et al. (2021) | |
| Jamaicin | A549 cancer cell line | Cytotoxic (IC50: 11.4 ± 5.0 mM) | Buyinza et al. (2021) | |
| Antibacterial activity | Millexatin A | Bacterial strains | Growth inhibition: S. aureus, S. epidermidis and B. subtilis (2 µg/mL); S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) |
| Millexatin F | Bacterial strains | Growth inhibition: S. aureus, S. epidermidis, and B. subtilis (2 µg/mL); S. typhyimurium and Ps. aeruginosa (128 2 µg/mL) | Raksat et al. (2018) | |
| Auriculatin | Bacterial strains | Growth inhibition: S. aureus, S. epidermidis, and B. subtilis (2 µg/mL); S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| 3'-Methylorobol | Bacterial strains | Growth inhibition: S. aureus (32 µg/mL), S. epidermidis and B. subtilis (64 µg/mL); S. typhyimurium and Ps. Aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| Scandenone | Bacterial strains | Growth inhibition: S. aureus and B. subtilis (2 µg/mL); S. epidermidis (4 µg/mL); S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| Auriculasin | Bacterial strains | Growth inhibition: S. aureus and S. epidermidis (4 µg/mL); B. subtilis (8 µg/mL); S. typhyimurium and Ps. Aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| 2'-Deoxyauriculasin | Bacterial strains | Growth inhibition: S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| Isoauroculatin | Bacterial strains | Growth inhibition: S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| Sumarol | Bacterial strains | Growth inhibition: S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| Maackiain | Bacterial strains | Growth inhibition: S. typhyimurium and Ps. aeruginosa (128 µg/mL) | Raksat et al. (2018) | |
| Millexatin I | Bacterial strains | Growth inhibition: M. luteus (64), S. mutans (128 µg/mL), S. epidermidis (128 µg/mL), S. cereus (64 µg/mL), S. aureus (64 µg/mL); S. typhimurium (128 µg/mL), S. flexneri (128 µg/mL) | Raksat et al. (2019) | |
| Millexatin J | Bacterial strains | Growth inhibition: M. luteus (32 µg/mL), S. mutans (128 µg/mL), S. epidermidis (128 µg/mL), S. typhimurium (128 µg/mL), E. coli (128 µg/mL) | Raksat et al. (2019) | |
| Millexatin K | Bacterial strains | Growth inhibition: M. luteus (64 µg/mL), S. mutans (128 µg/mL), S. epidermidis (128 µg/mL), S. cereus (32 µg/mL), S. aureus (32 µg/mL); S. typhimurium (128 µg/mL) | Raksat et al. (2019) | |
| Millexatin L | Bacterial strains | Growth inhibition: M. luteus (64 µg/mL), S. mutans (128 µg/mL), S. epidermidis (128 µg/mL), S. cereus (32 µg/mL), S. aureus (32 µg/mL); S. typhimurium (128 µg/mL) | Raksat et al. (2019) | |
| Millexatin M | Bacterial strains | Growth inhibition: S. epidermidis (128 µg/mL), S. cereus (128 µg/mL), S. aureus (128 µg/mL); S. typhimurium (128 µg/mL), S. flexneri (128 µg/mL) | Raksat et al. (2019) | |
| Millexatin B | Bacterial strains | Growth inhibition: S. epidermidis (128 µg/mL), S. aureus (128 µg/mL); S. typhimurium (128 µg/mL), | Raksat et al. (2019) | |
| Millexatin D | Bacterial strains | Growth inhibition: M. luteus (32 µg/mL), S. mutans (128 µg/mL), S. epidermidis (128 µg/mL), S. cereus (8 µg/mL), S. Aureus (8 µg/mL); S. typhimurium (128 µg/mL), S. aeuruginosa (128 µg/mL), E. coli (128 µg/mL) | Raksat et al. (2019) | |
| Millipurone | Bacterial strains | Growth inhibition: M. luteus (2 µg/mL), S. mutans (16 µg/mL), S. epidermidis (4 µg/mL), S. cereus (32 µg/mL), S. aureus (4 µg/mL); S. typhimurium (128 µg/mL), S. aeuruginosa (128 µg/mL), E. coli (128 µg/mL), S. flexneri (128 µg/mL) | Raksat et al. (2019) | |
| 5,7,3',4'-tetrahydroxy-6,8-diprenylisoflavone (6,8-Diprenyorobol) | Bacterial strains | Growth inhibition: M. luteus (16 µg/mL), S. mutans (16 µg/mL), S. epidermidis (128 µg/mL), S. cereus (16 µg/mL), S. aureus (32 µg/mL); S. typhimurium (128 µg/mL), S. aeuruginosa (128 µg/mL), E. coli (128 µg/mL), S. flexneri (128 µg/mL) | Raksat et al. (2019) | |
| 5-Hydroxy-7-methoxy-4'-O-(3-methylbut-2-enyl)isoflavone | Bacterial strains | Growth inhibition: S. aureus (32 µg/mL); S. epidermidis (128 µg/mL), S. typhimurium (128 µg/mL) | Raksat et al. (2019) | |
| 7,4'-di-O-prenylgenistein | Bacterial strains | S. aureus (32 µg/mL); S. epidermidis (128 µg/mL), S. typhimurium (128 µg/mL); S. flexneri (128 µg/mL) | Raksat et al. (2019) | |
| Estrogenic activity | Millewanin G | 17 β-estradiol induced yeast | Inhibition of β-galactosidase activity (IC50: 29 µM) | Ito et al. (2006) |
| Millewanin H | 17 β-estradiol induced yeast | Inhibition of β-galactosidase activity IC50: 18 µM) | Ito et al. (2006) | |
| Furowanin B | 17 β-estradiol induced yeast | Inhibition of β-galactosidase activity (IC50: 13 µM) | Ito et al. (2006) | |
| 4'-methoxy-7-O-[(E)-3-methyl-7-hydroxymethyl-2,6-octadienyl]isoflavone | Yeast strain; MVLN cells; Ishikawa cells | Induction of estradiol activity (S. sereviseae) (10–8 M); Induction of luciferase activity (10–6 M); AlkP induction (10−6 M) | Wanda et al. (2006) | |
| 3',4'-dihydroxy-7-O -[(E)-3,7-dimethyl-2,6-octadienyl]isoflavone M | Yeast strain; MVLN cells; Ishikawa cells | Induction of estradiol activity (10–8 M); Induction of luciferase activity (10−5 M); AlkP induction (10−5 M) | Wanda et al. (2006) | |
| 4'-O-geranylisoliquiritigenin | Yeast strain; MVLN cells; Ishikawa cells | Induction of estradiol activity (10–8 M); Induction of luciferase activity (10−6 M); AlkP induction (10−6 M) | Wanda et al. (2006) | |
| 7-O-geranylformononetin | Yeast strain; MVLN cells; Ishikawa cells | Induction of estradiol activity (10–8 M); Induction of luciferase activity (10−6 M); AlkP induction (10−7 M) | Wanda et al. (2006) | |
| Griffonianone C | Wanda et al. (2007) | |||
| Anti-Alzheimer ‘s | Deguelin | In vitro assay | Inhibition of AChE activity (IC50: 126.70 µM) | Tu et al. (2019) |
| Tephrosin | In vitro assay | Inhibition of AChE activity (IC50: 127.18 µM) | Tu et al. (2019) | |
| Barbigerone | In vitro assay | Inhibition of AChE (IC50: 121.60 µM) and BChE (IC50: 21.77 µM) activities | Tu et al. (2019) | |
| 4',5-dimethoxy-6,6-dimethylpyrano isoflavone | In vitro assay | Inhibition of AChE (IC50: 131.17 µM) and BChE (IC50: 2.34 µM) activities | Tu et al. (2019) | |
| Larvaecidal activity | Deguelin | Aedes aegypti larvae | Potent (IC50: 1.6 µg/mL) | Yenesew et al. (2003a) |
| Tephrosin | Aedes aegypti larvae | Potent (IC50: 1.4 µg/mL) | Yenesew et al. (2003a) | |
| Anticoagulative activities | Genistein | Male New Zealand white rabbits | Dose-dependent antithrobin activity | Liao et al. (2013) |
| Daidzein | Male New Zealand white rabbits | Dose-dependent antithrobin activity | Liao et al. (2013) | |
| 5,7,2',4'-tetrahydroxyisolfavone | Male New Zealand white rabbits | Dose-dependent antithrobin activity | Liao et al. (2013) | |
| Antioxidant activity | Robustigenin, Viridiflorin, 12a-hydroxy-a -toxicarol | TLC-spot DPPH-Assay | Radical scavenging activity | Pancharoen et al. (2008) |
| Antiplasmodial activity | calopogonium isoflavone B; | 3D7 and the Dd2 strains of Plasmodium falciparum | 70–90% inhibition (40 µM) | Marco et al. (2017) |
| Isoerythrin A-4′-(3-methylbut-2-enyl) ether | 70–90% inhibition (40 µM) | Marco et al. (2017) |
Anti-inflammatory activities
Several in vitro and in vivo studies have shown that the various classes of Millettia isoflavonoids have anti-inflammatory properties. In vitro studies with macrophage cells (RAW264.7) showed that (3S)-vestitol (3), Brandisianin A (46), scandenone (78), diprenyorobol (56), cis-3'',4''-Dihydro-3'',4''-Dihydroxylonchocapusone (104) and 6,8-milletenol A (107) inhibit the production of NO, one of the known inflammatory mediators (Dat et al. 2019; Pancharoen et al. 2008; Raksat et al. 2019; Tang et al. 2016; Tu et al. 2020). The IC50 values of these molecules ranged from 8.5 to 35.7 µM (Table 2), with scandenone being the most potent molecule (Raskat et al. 2019). Other in vivo studies have shown that griffonianone D (113) inhibits swelling in ATP and PLA2-induced edema assays (Yankep et al. 2003). 6-Deoxyclitoriacetal (126) and α-toxicarol (119) have also been shown to have similar activities (Pancharoen et al. 2008). Despite these promising results, many of the isolated molecules from these nine Millettia species have rarely been studied for their anti-inflammatory activities, suggesting that there is a huge research potential for future studies.
Anticancer activities
The anticancer activities of several Millettia isoflavonoids have been assessed using different kinds of cancer cells. For example, 7,2-dimethyl-4',5'-dimethylenedioxyisoflavone (23), maximaisoflavone B (109), millettosin (129), 4'-O-geranylisoliquiritigenin (114), usararotenoid A (132), usararotenoid C (133), griffonianone C, and 12a-epimillettosin (141) were found to be cytotoxic to breast cancer cells, of which the former was the most potent (IC50: 25.7 µM) to MDB-MB-231 cancer cells (Deyou et al. 2015; Marco et al. 2017; Wanda et al. 2011). In other studies, brandisianin B (106), brandisianin C (54) and brandisianin E (55) were found to be cytotoxic to colon cancer cells, while barbigerone (91), deguelin (127), 13-homo13-oxa-6a,12a-dehydrodeguelin (136), tephrosin (118), and 6a,12a-dehydrodeguelin (137) were found to induce aptosis in liver, lung and colorectal cancer cells (Kikuchi et al. 2007; Ye et al. 2012a, b). A recent study by Buyinza et al. (2021) also showed the cytotoxicity of durmillone (94) and jamaicin (96) to adenocarcenomic human alveolar cancer cells at low concentrations (IC50: 6.6 and 11.4 µM, respectively). These findings indicate the potential of Millettia isoflavonoids in cancer treatment and, as such, warrant close attention in the future. Furthermore, many of the anticancer studies were conducted in vitro, and additional in vivo studies are strongly advised to support the observed in vitro results.
Estrogenic activities
In comparison to their anti-inflammatory and anticancer activities, the estrogenic activities of Millettia isoflavonoids have received little attention. Ito et al. (2006) demonstrated in vitro that furowanin B (50), millewanin G (57) and millewanin H (58) inhibit β-galactosidase activity in β-estradiol-induced yeast cells, with the former being the most active inhibitor (IC50: 13 µM). In another study, Wand et al. (2006) showed the simultaneous induction of estradiol activity and luciferase activity by 4'-methoxy-7-O-[(E)-3-methyl-7-hydroxymethyl-2,6-octadienyl]isoflavone (115), 3',4'-dihydroxy-7-O-[(E)-3,7-dimethyl-2,6-octadienyl]isoflavone M (111), 4'-O-geranylisoliquiritigenin (114), and 7-O-geranylformononetin (110) in different cells. These findings highlight the importance of Millettia isoflavonoids in combating the negative health effects of endocrine disruption. The lack of detailed studies in this area suggests a great opportunity for future research on unstudied isolated isoflavonoids.
Antibacterial activities
Compared to the aforementioned biological activities, the antibacterial activities of the isolated Millettia isoflavonoids have rarely been investigated. However, two studies by Raksat et al. (2018, 2019) extensively investigated the antibacterial activities of isoflavonoids isolated from M. extensa and found that they inhibited the growth of both gram-positive and gram-negative bacterial strains (Table 2). For example, scandenone (78) inhibited the growth of Staphylococcus aureus (S. aureus) and Bacillus subtilis (B. subtilis) at MICs of 2 µg/mL and S. epidermidis at MICs of 4 µg/mL (Raksat et al. 2018). Similarly, several millexatin isoflavonoids inhibited the growth of several bacterial strains at different MIC levels (Table 3). These findings suggest that isoflavonoid-rich extracts of Millettia species could be used as food preservatives. Moreover, further research into the antibacterial properties of Millettia isoflavonoids is highly recommended.
Other pharmacological properties
In addition to the pharmacological activities mentioned above, some Millettia isoflavonoids were tested for other biological activities. For example, independent in vitro studies by Tu et al. (2019) and Yenesew et al. (2003a) showed the anti-Alzheimer’s and larvicidal potentials of both degulin (127) and tephrosin (118), respectively (Table 2). In another study, genistein (5) and daidzein (4) demonstrated dose-dependent antithrobin activity, indicating their potential as anticoagulant molecules (Liao et al. 2013). The antioxidant activities of robustigenin (12), viridflorin (48), and 12a-hydroxy-α-toxicarol (120) (Pacharoen et al. 2008) and the antiplasmodial activities of calopoginiumisoflavone B (95) and isoerythrinin-A-4′-(3-methylbut-2-enyl) ether (92) (Marco et al. 2017) were among the other biological activities studied. Many rotenoids have pesticide activity and are used to control a variety of insects (Lin et al. 2016). Rotenoids isolated from Millettia species, such as tephrosin (118) and rotenone (130), were also discovered to possess these critical properties. In general, these findings highlight the fact that most of the isolated isoflavonoids have not been studied for various pharmacological activities and thus could be a future research focus.
Conclusion and prospects
Millettia species have received much attention in recent years because of their wide distribution, diverse pharmacological properties and rich metabolite contents. Isoflavonoids are one of the most important secondary metabolites found in Millettia species, and they have several disease-deterrence and health-promoting properties. This review revealed that structurally diverse classes of isoflavonoids are abundant in all plant tissues of Millettia species. Flowers and seed coats are rarely studied in comparison to other plant parts, so future research into these tissues is highly encouraged. Furthermore, in vivo assays and clinical trials would be critical for validating the promising pharmacological activities of Millettia isoflavonoids. Overall, this review summarizes the structural diversity, trends in extraction and isolation protocols, structural analysis techniques, and pharmacological properties of Millettia isoflavonoids, potentially paving the way for fruitful and impactful research lines in Millettia species and their isoflavonoids.
Supplementary Information
Below is the link to the electronic supplementary material.
Abbreviations
- AChE
Acetylcholinesterase
- BChE
Butyrylcholinesterase
- CC
Column chromatography
- CCC
Countercurrent chromatography
- CD
Circular dichroism
- COSY
Correlation spectroscopy
- COVID
Coronavirus disease
- ECD
Electronic circular dichroism
- HMBC
Heteronuclear multiple bond correlation
- HPLC
High-performance liquid chromatography
- HR-MS
High resolution mass spectrometry
- HSCCC
High-speed countercurrent chromatography
- HSQC
Heteronuclear single quantum coherence
- IR
Infrared spectroscopy
- MIC
Minimum inhibitory concentration
- MS
Mass spectrometry
- NMR
Nuclear magnetic resonance spectroscopy
- P-HPLC
Preparative high-performance liquid chromatography
- P-TLC
Preparative thin layer chromatography
- RP-HPLC
Reverse-phase high-performance liquid chromatography
- TLC
Thin layer chromatography
- UV–Vis
Ultraviolet–visible spectroscopy
- VLC
Vacuum-liquid chromatography
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Declarations
Conflict of interest
The authors declare they have no conflicts of interest.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- Alesawy MS, Abdallah AE, Taghour MS, Elkaeed EB, Eissa HI, Metwaly AM. In silico studies of some isoflavonoids as potential candidates against COVID-19 targeting human ACE2 (hACE2) and viral main protease (Mpro) Molecules. 2021;26(9):2806. doi: 10.3390/molecules26092806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Al-Maharik N. Isolation of naturally occurring novel isoflavonoids: an update. Nat Prod Rep. 2019;36(8):1156–1195. doi: 10.1039/c8np00069g. [DOI] [PubMed] [Google Scholar]
- Banzouzi J, Prost A, Rajemiarimiraho M, Ongoka P. Traditional uses of the African Millettia species (Fabaceae) Int J Botany. 2008;4(4):406–420. doi: 10.3923/ijb.2008.406.420. [DOI] [Google Scholar]
- Bhargavan B, Gautam AK, Singh D, Kumar A, Chaurasia S, Tyagi AM, et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem. 2009;108(2):388–399. doi: 10.1002/jcb.22264. [DOI] [PubMed] [Google Scholar]
- Botta B, Menendez P, Zappia G, de Lima RA, Torge R, Monache GD. Prenylated isoflavonoids: botanical distribution, structures, biological activities and biotechnological studies. an update (1995–2006) Curr Med Chem. 2009;16(26):3414–3468. doi: 10.2174/092986709789057662. [DOI] [PubMed] [Google Scholar]
- Bueno-Silva B, Alencar SM, Koo H, Ikegaki M, Silva GVJ, Napimoga MH, et al. Anti-inflammatory and antimicrobial evaluation of Neovestitol and Vestitol isolated from brazilian red propolis. J Agric Food Chem. 2013;61(19):4546–4550. doi: 10.1021/jf305468f. [DOI] [PubMed] [Google Scholar]
- Buyinza D, Chalo DM, Derese S, Ndakala A, Yenesew A. Flavonoids and Isoflavonoids of Millettia dura and Millettia ferruginea: Phytochemical review and chemotaxonomic values. Biochem Syst Ecol. 2020;91:104053. doi: 10.1016/j.bse.2020.104053. [DOI] [Google Scholar]
- Buyinza D, Yang LJ, Derese S, Ndakala A, Coghi P, Heydenreich M, et al. Cytotoxicity of isoflavones from Millettia dura. Nat Prod Res. 2021;35(16):2744–2747. doi: 10.1080/14786419.2019.1660335. [DOI] [PubMed] [Google Scholar]
- Cayetano-Salazar L, Olea-Flores M, Zuñiga-Eulogio MD, Weinstein-Oppenheimer C, Fernández-Tilapa G, Mendoza-Catalán MA, et al. Natural isoflavonoids in invasive cancer therapy: from bench to bedside. Phytother Res. 2021;35(8):4092–4110. doi: 10.1002/ptr.7072. [DOI] [PubMed] [Google Scholar]
- Chebil L, Humeau C, Falcimaigne A, Engasser J-M, Ghoul M. Enzymatic acylation of flavonoids. Process Biochem. 2006;41(11):2237–2251. doi: 10.1016/j.procbio.2006.05.027. [DOI] [Google Scholar]
- Cheng J, Zhao Y-Y, Wang B, Qiao L, Liang H. Flavonoids from Millettia nitida var. hirsutissima. Chem Pharm Bull. 2005;53(4):419–421. doi: 10.1248/cpb.53.419. [DOI] [PubMed] [Google Scholar]
- Ciesielski P, Metz P. Asymmetric one-pot transformation of isoflavones to pterocarpans and its application in phytoalexin synthesis. Nat Commun. 2020;11(1):3091. doi: 10.1038/s41467-020-16933-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dat LD, Tu NTM, Duc NV, Luyen BTT, Huyen CTT, Jang HJ, et al. Anti-inflammatory secondary metabolites from the stems of Millettia dielsiana Harms ex Diels. Carbohydr Res. 2019;484:107778. doi: 10.1016/j.carres.2019.107778. [DOI] [PubMed] [Google Scholar]
- Deyou T, Gumula I, Pang F, Gruhonjic A, Mumo M, Holleran J, et al. Rotenoids, flavonoids, and chalcones from the root bark of Millettia usaramensis. J Nat Prod. 2015;78(12):2932–2939. doi: 10.1021/acs.jnatprod.5b00581. [DOI] [PubMed] [Google Scholar]
- Dixon RA. Isoflavonoids: biochemistry, molecular biology and biological functions. Compr Nat Prod Chem. 1999;1:773–823. doi: 10.1016/b978-0-08-091283-7.00030-8. [DOI] [Google Scholar]
- Fahmy NM, Al-Sayed E, El-Shazly M, Singab AN. Comprehensive review on flavonoids biological activities of Erythrina plant species. Ind Crops Prod. 2018;123:500–538. doi: 10.1016/j.indcrop.2018.06.028. [DOI] [Google Scholar]
- Farajzadeh-Dehkordi M, Darzi S, Rahmani B, Farhadian S. A novel insight into the cytotoxic effects of Tephrosin with calf thymus DNA: experimental and in silico approaches. J Mol Liq. 2021;324:114728. doi: 10.1016/j.molliq.2020.114728. [DOI] [Google Scholar]
- Felpin F-X, Lory C, Sow H, Acherar S. Practical and efficient entry to isoflavones by Pd(0)/C-mediated Suzuki-Miyaura reaction total synthesis of Geranylated Isoflavones. Tetrahedron. 2007;63(14):3010–3016. doi: 10.1016/j.tet.2007.01.062. [DOI] [Google Scholar]
- Feng Z-G, Bai W-J, Pettus TRR. Unified total syntheses of (−)-Medicarpin, (−)-Sophoracarpan A, and (±)-Kushecarpin a with some structural revisions. Angew Chem Int Ed Engl. 2015;54(6):1864–1867. doi: 10.1002/anie.201408910. [DOI] [PubMed] [Google Scholar]
- Fitzgerald M, Heinrich M, Booker A. Medicinal plant analysis: a historical and regional discussion of emergent complex techniques. Front Pharmacol. 2020;10:1480. doi: 10.3389/fphar.2019.01480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franchin M, Cólon DF, Castanheira FVS, da Cunha MG, Bueno-Silva B, Alencar SM, et al. Vestitol isolated from brazilian red propolis inhibits neutrophils migration in the inflammatory process: elucidation of the mechanism of action. J Nat Prod. 2016;79(4):954–960. doi: 10.1021/acs.jnatprod.5b00938. [DOI] [PubMed] [Google Scholar]
- Gathungu RM, Kautz R, Kristal BS, Bird SS, Vouros P. The integration of LC-MS and NMR for the analysis of low molecular weight trace analytes in complex matrices. Mass Spectrom Rev. 2020;39(1–2):35–54. doi: 10.1002/mas.21575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goel A, Kumar A, Raghuvanshi A. Synthesis, stereochemistry, structural classification, and chemical reactivity of natural Pterocarpans. Chem Rev. 2013;113(3):1614–1640. doi: 10.1021/cr300219y. [DOI] [PubMed] [Google Scholar]
- Gong T, Wang D-X, Chen R-Y, Liu P, Yu D-Q. Novel benzil and Isoflavone derivatives from Millettia dielsiana. Planta Med. 2009;75(03):236–242. doi: 10.1055/s-0028-1112203. [DOI] [PubMed] [Google Scholar]
- Gong T, Zhang T, Wang DX, Chen RY, Liu P, Yu DQ. Two new isoflavone glycosides from the vine stem of Millettia dielsiana. J Asian Nat Prod Res. 2014;16(2):181–186. doi: 10.1080/10286020.2013.860967. [DOI] [PubMed] [Google Scholar]
- Hanh Nguyen TT, Jin J, Septiana I, Quereshi D, Pal K, Kim D. Enzymatic synthesis of flavonoid glucosides and their biochemical characterization. In: Pal K, Banerjee I, Sarkar P, Kim D, Deng W-P, Dubey NK, Majumder K, editors. Biopolymer-based formulations. Heidelberg: Elsevier; 2020. [Google Scholar]
- Hussain H, Green IR. A patent review of the therapeutic potential of isoflavones (2012–2016) Expert Opin Ther Pat. 2017;27(10):1135–1146. doi: 10.1080/13543776.2017.1339791. [DOI] [PubMed] [Google Scholar]
- Ito C, Itoigawa M, Kumagaya M, Okamoto Y, Ueda K, Nishihara T, et al. Isoflavonoids with antiestrogenic activity from Millettia pachycarpa. J Nat Prod. 2006;69(1):138–141. doi: 10.1021/np050341w. [DOI] [PubMed] [Google Scholar]
- Ivanović M, Islamčević Razboršek M, Kolar M. Innovative extraction techniques using deep eutectic solvents and analytical methods for the isolation and characterization of natural bioactive compounds from plant material. Plants (basel) 2020;9(11):1428. doi: 10.3390/plants9111428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jena R, Rath D, Rout SS, Kar DM. A review on genus Millettia: traditional uses, phytochemicals and pharmacological activities. Saudi Pharm J. 2020;28(12):1686–1703. doi: 10.1016/j.jsps.2020.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jung W, Yu O, Lau S-MC, O’Keefe DP, Odell J, Fader G, et al. Identification and expression of isoflavone synthase, the key enzyme for biosynthesis of isoflavones in legumes. Nat Biotech. 2000;18(2):208–212. doi: 10.1038/72671. [DOI] [PubMed] [Google Scholar]
- Kalli S, Araya-Cloutier C, Hageman J, Vincken J-P. Insights into the molecular properties underlying antibacterial activity of prenylated (iso)flavonoids against MRSA. Sci Rep. 2021;11(1):14180. doi: 10.1038/s41598-021-92964-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khouri HE, Tahara S, Ibrahim RK. Partial purification, characterization, 5-O-Methyltransferase and kinetic analysis of lsoflavone from yellow Lupin roots’. Arch Biochem Biophys. 1988;262(2):592–598. doi: 10.1016/0003-9861(88)90410-9. [DOI] [PubMed] [Google Scholar]
- Kikuchi H, Ohtsuki T, Koyano T, Kowithayakorn T, Sakai T, Ishibashi T. Brandisianins A-F, isoflavonoids isolated from Millettia brandisiana in a screening program for death-receptor expression enhancement activity. J Nat Prod. 2007;70(12):1910–1914. doi: 10.1021/np0703904. [DOI] [PubMed] [Google Scholar]
- Kikuchi H, Ohtsuki T, Koyano T, Kowithayakorn T, Sakai T, Ishibashi M. Death receptor 5 targeting activity-guided isolation of isoflavones from Millettia brandisiana and Ardisia colorata and evaluation of ability to induce TRAIL-mediated apoptosis. Bioorg Med Chem. 2009;17(3):1181–1186. doi: 10.1016/j.bmc.2008.12.033. [DOI] [PubMed] [Google Scholar]
- Kumar M, Dahuja M, Tiwari S, Punia S, Tak Y, Amarowicz R, Bhoite AG, Singh S, Joshi S, Panesar PS. Recent trends in extraction of plant bioactives using green technologies: a review. Food Chem. 2021;353:129431. doi: 10.1016/j.foodchem.2021.129431. [DOI] [PubMed] [Google Scholar]
- Lewis P, Kalita S, Wahala K. The phase transfer catalyzed synthesis of isoflavone-O-glucosides. J Chem Soc Perkin Trans. 1998;1:2481–2484. doi: 10.1039/a804406f. [DOI] [Google Scholar]
- Li H-Q, Ge H-M, Chen Y-X, Xu C, Shi L, Ding H, et al. Synthesis and cytotoxic evaluation of a series of Genistein derivatives. Chem Biodivers. 2006;3(4):463–672. doi: 10.1002/cbdv.200690049. [DOI] [PubMed] [Google Scholar]
- Liao X-L, Luo J-G, Kong L-Y. Flavonoids from Millettia nitida var. hirsutissima with their anticoagulative activities and inhibitory effects on NO production. J Nat Med. 2013;67(4):856–861. doi: 10.1007/s11418-013-0745-4. [DOI] [PubMed] [Google Scholar]
- Lin TX, Gong MF, Guan QL, Mao JN. Insecticidal Activity of crude extract from seeds of Millettia Pachyarpa on cabbage aphid. Environ Sci Sust Dev. 2016 doi: 10.1142/9789814723039_0057. [DOI] [Google Scholar]
- Luniwal A, Erhardt P. Total syntheses of (±)-Vestitol and Bolusanthin III using a Wittig strategy. Synlett. 2011;11:1605–1607. doi: 10.1055/s-0030-1260783. [DOI] [Google Scholar]
- Mackova Z, Koblovska R, Lapcik O. Distribution of isoflavonoids in non-leguminous taxa – An update. Phytochemistry. 2006;67(9):849–855. doi: 10.1016/j.phytochem.2006.01.020. [DOI] [PubMed] [Google Scholar]
- Magloire WGJ, Ketcha ND, Tagatsing FM, Yankep E, Vollmer G. Regulation of CD1, Ki-67, PCNA mRNA expression, and Akt activation in estrogen-responsive human breast adenocarcinoma cell line, MCF-7 cells, by griffonianone C, an isoflavone derived from Millettia griffoniana. Pharm Biol. 2011;49(4):341–347. doi: 10.3109/13880209.2010.517210. [DOI] [PubMed] [Google Scholar]
- Marco M, Deyou T, Gruhonjic A, Holleran J, Duffy S, Heydenreich M, et al. Pterocarpans and isoflavones from the root bark of Millettia micans and of Millettia dura. Phytochem Lett. 2017;21:216–220. doi: 10.1016/j.phytol.2017.07.012. [DOI] [Google Scholar]
- Mora-Pale M, Sanchez-Rodriguez SP, Linhardt RJ, Dordick JS, Koffas MAG. Metabolic engineering and in vitro biosynthesis of phytochemicals and non-natural analogues. Plant Sci. 2013;210:10–24. doi: 10.1016/j.plantsci.2013.05.005. [DOI] [PubMed] [Google Scholar]
- Mukne A, Viswanathan V, Phadatare A. Structure pre-requisites for isoflavones as effective antibacterial agents. Pharmacogn Rev. 2011;5(9):13–18. doi: 10.4103/0973-7847.79095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mutai P, Pavadai E, Wiid I, Ngwane A, Baker B, Chibale K. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin. Bioorg Med Chem Lett. 2015;25(12):2510–2513. doi: 10.1016/j.bmcl.2015.04.064. [DOI] [PubMed] [Google Scholar]
- Nakayama M, Ohira S, Matsui T. Synthesis of 5, 7-Dihydroxy-2′, 4′, 5′-trimethoxyisoflavone and Its 7-Methyl Ether (Robustigenin) Bull Chem Soc Jpn. 1980;53(3):831–832. doi: 10.1246/bcsj.53.831. [DOI] [Google Scholar]
- Ngameni B, Fotso GW, Kamga J, Ambassa P, Abdou T, Fankam AG, et al. Flavonoids and Related Compounds from the Medicinal Plants of Africa. In: Kuete V, et al., editors. Medicinal Plant Research in Africa. Heidelberg: Elsevier; 2013. pp. 301–350. [Google Scholar]
- Ngamga D, Free SF, Tane P, Fomum ZT. Millaurine A, a new guanidine alkaloid from seeds of Millettia laurentii. Fitoterapia. 2007;78(3):276–277. doi: 10.1021/np0703904. [DOI] [PubMed] [Google Scholar]
- Ningombam A, Ahluwalia V, Srivastava C, Walia S. Antifeedant activity and phytochemical investigation of Millettia pachycarpa extracts against Tobacco Leaf Eating Caterpillar, Spodoptera litura (Fabricius) (Lepidoptera: Noctuidae) J Asia Pac Entomol. 2017;20(2):381–385. doi: 10.1016/j.aspen.2017.01.012. [DOI] [Google Scholar]
- Ozaki Y, Mochida K, Kim SW. Total synthesis of sophorapterocarpan A, maackiain, and anhydropisatin: application of a 1, 3-Michael-Claisen annulation to aromatic synthesis. J Chem Soc Perkin Trans. 1989;7:1219–1224. doi: 10.1039/p19890001219. [DOI] [Google Scholar]
- Pailee P, Mahidol C, Ruchirawat S, Prachyawarakorn V. Diverse flavonoids from the roots of Millettia brandisiana. Phytochemistry. 2019;162:157–164. doi: 10.1016/j.phytochem.2019.03.013. [DOI] [PubMed] [Google Scholar]
- Pancharoen O, Athipornchai A, Panthong A, Taylor WC. Isoflavones and Rotenoids from the leaves of Millettia brandisiana. Chem Pharm Bull. 2008;56(6):835–838. doi: 10.1248/cpb.56.835. [DOI] [PubMed] [Google Scholar]
- Perveen S, Yang S, Meng M, Xu W, Zhang G, Fang X. Asymmetric total synthesis of rotenoids via organocatalyzed dynamic kinetic resolution. Commun Chem. 2019;2(1):1–8. doi: 10.1038/s42004-019-0110-y. [DOI] [Google Scholar]
- Prasansuklab A, Theerasri A, Rangsinth P, Sillapachaiyaporn C, Chuchawankul S, Tencomnao T. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. J Tradit Complement Med. 2021;11(2):144–157. doi: 10.1016/j.jtcme.2020.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Raksat A, Maneerat W, Andersen RJ, Pyne SG, Laphookhieo S. Antibacterial Prenylated Isoflavonoids from the Stems of Millettia extensa. J Nat Prod. 2018;81(8):1835–1840. doi: 10.1021/acs.jnatprod.8b00321. [DOI] [PubMed] [Google Scholar]
- Raksat A, Maneerat W, Rujanapun N, Andersen RJ, Pyne SG, Laphookhieo S. Antibacterial and inhibitory activities against nitric oxide production of Coumaronochromones and Prenylated Isoflavones from Millettia extensa. J Nat Prod. 2019;82(8):2343–2348. doi: 10.1021/acs.jnatprod.9b00216. [DOI] [PubMed] [Google Scholar]
- Reynaud J, Guilet D, Terreux R, Lussignol M, Walchshofer N. Isoflavonoids in non-leguminous families: an update. Nat Prod Rep. 2005;22(4):504–515. doi: 10.1039/b416248j. [DOI] [PubMed] [Google Scholar]
- Roy B, Bharti RR. Millettia Pachycarpa benth: a herbal medicinal plant of Southeast Asia. In: Patra J, Shukla A, Das G, editors. Advances in pharmaceutical biotechnology. Springer; 2020. pp. 175–191. [Google Scholar]
- Russell DA, Freudenreich JJ, Stewart HL, Bond AD, Sore HF, Spring DR. Semi-syntheses of the 11-hydroxyrotenoids sumatrol and villosinol. Org Biomol Chem. 2018;16(35):6395–6398. doi: 10.1039/c8ob01919c. [DOI] [PubMed] [Google Scholar]
- Santos CMM, Silva AMS. The antioxidant activity of Prenylflavonoids. Molecules. 2020;25(3):696. doi: 10.3390/molecules25030696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seeger M, González M, Cámara B, Muñoz L, Ponce E, Mejías L, et al. Biotransformation of natural and synthetic Isoflavonoids by two recombinant microbial enzymes. Appl Environ Microbiol. 2003;69(9):5045–5050. doi: 10.1128/AEM.69.9.5045-5050.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selepe M, Van Heerden F. Application of the Suzuki-Miyaura reaction in the synthesis of flavonoids. Molecules. 2013;18(4):4739–4765. doi: 10.3390/molecules18044739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simons R, Gruppen H, Bovee TFH, Verbruggen MA, Vincken JP. Prenylated isoflavonoids from plants as selective estrogen receptor modulators (phytoSERMs) Food Func. 2012;3(8):810. doi: 10.1039/c2fo10290k. [DOI] [PubMed] [Google Scholar]
- Sisa M, Bonnet SL, Ferreira D, Van der Westhuizen JH. Photochemistry of flavonoids. Molecules. 2010;15(8):5196–5245. doi: 10.3390/molecules15085196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sohn SI, Pandian S, Oh YJ, Kang HJ, Cho WS, Cho YS. Metabolic engineering of Isoflavones: an updated overview. Front Plant Sci. 2021;12:1–17. doi: 10.3389/fpls.2021.670103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stevenson AJ, Ager EI, Proctor MA, Škalamera D, Heaton A, Brown D, et al. Mechanism of action of the third generation benzopyrans and evaluation of their broad anti-cancer activity in vitro and in vivo. Sci Rep. 2018;8(1):1–11. doi: 10.1038/s41598-018-22882-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun H, Li Y, Zhang X, Lei Y, Ding W, Zhao X, et al. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones. Bioorg Med Chem Lett. 2015;25(20):4567–4571. doi: 10.1016/j.bmcl.2015.08.059. [DOI] [PubMed] [Google Scholar]
- Szeja W, Grynkiewicz G, Rusin A. Isoflavones, their glycosides and glycoconjugates. synthesis and biological activity. Curr Org Chem. 2017;21(3):218–235. doi: 10.2174/1385272820666160928120822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang H, Pei H-Y, Wang T-J, Chen K, Wu B, Yang Q-N, et al. Flavonoids and biphenylneolignans with anti-inflammatory activity from the stems of Millettia griffithii. Bioorg Med Chem Lett. 2016;26(18):4417–4422. doi: 10.1016/j.bmcl.2016.08.009. [DOI] [PubMed] [Google Scholar]
- Tay K-C, Tan LT-H, Chan CK, Hong SL, Chan K-G, Yap WH, et al. Formononetin: a review of its anticancer potentials and mechanisms. Front Pharmacol. 2019;10:820. doi: 10.3389/fphar.2019.00820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsimogiannis D, Oreopoulou V (2019) Classification of Phenolic Compounds in Plants. In: Ronald Ross Watson (eds.) Polypehnols in Plants. 263–284. Academic Press.
- Tu Y, Wu C, Kang Y, Li Q, Zhu C, Li Y. Bioactivity-guided identification of flavonoids with cholinesterase and β-amyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa. Bioorg Med Chem Lett. 2019;29:1194–1198. doi: 10.1016/j.bmcl.2019.03.024. [DOI] [PubMed] [Google Scholar]
- Tu YB, Xiao T, Gong GY, Bian YQ, Li YF. A new isoflavone with anti-inflammatory effect from the seeds of Millettia pachycarpa. Nat Prod Res. 2020;34(7):981–987. doi: 10.1080/14786419.2018.1547294. [DOI] [PubMed] [Google Scholar]
- T-ul QM, Alqahtani SM, Alamri MA, Chen L-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313–319. doi: 10.1016/j.jpha.2020.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Veitch NC. Isoflavonoids of the Leguminosae. Nat Prod Rep. 2013;30(7):988–1027. doi: 10.1039/c3np70024k. [DOI] [PubMed] [Google Scholar]
- Vitale DC, Piazza C, Melilli B, Drago F, Salomone S. Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet. 2012;38(1):15–25. doi: 10.1007/s13318-012-0112-y. [DOI] [PubMed] [Google Scholar]
- Walle T. Methylation of dietary flavones increases their metabolic stability and Chemopreventive effects. Int J Mol Sci. 2009;10(11):5002–5019. doi: 10.3390/ijms10115002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wanda GJ, Njamen D, Yankep E, Fotsing MT, Fomum ZT, Wober J, Starcke S, Zierau O, Vollmer G. Estrogenic properties of isoflavones derived from Millettia griffoniana. Phytomedicine. 2006;13(3):139–145. doi: 10.1016/j.phymed.2005.06.003. [DOI] [PubMed] [Google Scholar]
- Wanda GJMK, Starcke S, Zierau O, Njamen D, Richter T, Vollmer G. Estrogenic activity of Griffonianone C, an Isoflavone from the root bark of Millettia griffoniana: regulation of the expression of estrogen responsive genes in uterus and liver of Ovariectomized rats. Planta Med. 2007;73(6):512–518. doi: 10.1055/s-2007-967186. [DOI] [PubMed] [Google Scholar]
- Wu L, Wang X, Xu W, Farzaneh F, Xu R. The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem. 2009;16(32):4236–4260. doi: 10.2174/092986709789578187. [DOI] [PubMed] [Google Scholar]
- Xu S, Wang G, Xu F, Li W, Lin A, Yao H, et al. Concise total synthesis of (±)-Deguelin and (±)-Tephrosin using a vinyl iodide as a key building block. J Nat Prod. 2018;81(4):1055–1059. doi: 10.1021/acs.jnatprod.7b00794. [DOI] [PubMed] [Google Scholar]
- Yalamanchili C, Chittiboyina AG, Chandra Kumar Rotte S, Katzenellenbogen JA, Helferich WG, Khan IA. A chiral pool approach for asymmetric syntheses of both antipodes of equol and sativan. Tetrahedron. 2018;74(16):2020–2029. doi: 10.1016/j.tet.2018.03.004. [DOI] [Google Scholar]
- Yamaki K, Kim DH, Ryu N, Kim YP, Shin KH, Ohuchi K. Effects of naturally occurring isoflavones on prostaglandin E2 production. Planta Med. 2002;68(02):97–100. doi: 10.1055/s-2002-20263. [DOI] [PubMed] [Google Scholar]
- Yang X, Zhao Y, Hsieh M-T, Xin G, Wu R-T, Hsu P-L, et al. Total synthesis of (+)-Medicarpin. J Nat Prod. 2017;80(12):3284–3288. doi: 10.1021/acs.jnatprod.7b00741. [DOI] [PubMed] [Google Scholar]
- Yankep E, Fomum ZT, Dagne E. An O-geranylated isoflavone from Millettia griffoniana. Phytochemistry. 1997;46(3):51–53. doi: 10.1016/S0031-9422(97)00326-9. [DOI] [Google Scholar]
- Yankep E, Fomum ZT, Bisrat D, Dagne E, Hellwig V, Steglich W. O-Geranylated isoflavones and a 3-phenylcoumarin from Millettia griffoniana. Phytochemistry. 1998;49(8):2521–2523. doi: 10.1016/S0031-9422(98)00392-6. [DOI] [Google Scholar]
- Yankep E, Mbafor JT, Fomum ZT, Steinbeck C, Messanga BB, Nyasse B, et al. Further isoflavonoid metabolites from Millettia griffoniana (Bail) Phytochemistry. 2001;56:363–368. doi: 10.1016/S0031-9422(00)00400-3. [DOI] [PubMed] [Google Scholar]
- Yankep E, Njamen D, Fotsing MT, Fomum ZT, Mbanya JC, Giner RM, Ríos JL. Griffonianone D, an Isoflavone with anti-inflammatory activity from the root bark of Millettia griffoniana. J Nat Prod. 2003;66(9):1288–1290. doi: 10.1021/np0205912. [DOI] [PubMed] [Google Scholar]
- Ye H, Chen L, Li Y, Peng A, Fu A, Song H, et al. Preparative isolation and purification of three rotenoids and one isoflavone from the seeds of Millettia pachycarpa Benth by high-speed counter-current chromatography. J Chromatogr A. 2008;1178(1–2):101–107. doi: 10.1016/j.chroma.2007.11.060. [DOI] [PubMed] [Google Scholar]
- Ye H, Zhong S, Li Y, Tang M, Peng A, Hu J, et al. Enrichment and isolation of barbigerone from Millettia pachycarpa Benth. using high-speed counter-current chromatography and preparative HPLC. J Sep Sci. 2010;33:1010–1017. doi: 10.1002/jssc.200900641. [DOI] [PubMed] [Google Scholar]
- Ye H, Fu A, Wu W, Li Y, Wang G, Tang M, et al. Cytotoxic and apoptotic effects of constituents from Millettia pachycarpa Benth. Fitoterapia. 2012;83(8):1402–1408. doi: 10.1016/j.fitote.2012.08.001. [DOI] [PubMed] [Google Scholar]
- Ye M, Yang W-Z, Liu K-D, Qiao X, Li B-J, Cheng J, et al. Characterization of flavonoids in Millettia nitida var. hirsutissima by HPLC/DAD/ESI-MSn. J Pharm Anal. 2012;2(1):35–42. doi: 10.1016/j.jpha.2011.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ye H, Wu W, Liu Z, Xie C, Tang M, Li S, et al. Bioactivity-guided isolation of anti-inflammation flavonoids from the stems of Millettia dielsiana Harms. Fitoterapia. 2014;95:154–159. doi: 10.1016/j.fitote.2014.03.008. [DOI] [PubMed] [Google Scholar]
- Yenesew A, Midiwo JO, Waterman PG. Four isoflavones from seed pods of Millettia dura. Phytochemistry. 1996;41(3):951–955. doi: 10.1016/0031-9422(95)00662-1. [DOI] [Google Scholar]
- Yenesew A, Midiwo JO, Waterman PG. 6-Methoxycalpogonium isoflavone A: a new isoflavone from the seed pods of Millettia dura. J Nat Prod. 1997;60(8):806–807. doi: 10.1021/np9605955. [DOI] [Google Scholar]
- Yenesew A, Midiwo JO, Waterman PG. Rotenoids, isoflavones and chalcones from the stem bark of Millettia usaramensis subspecies usaramensis. Phytochemistry. 1998;47(2):295–300. doi: 10.1016/S0031-9422(97)00424-X. [DOI] [Google Scholar]
- Yenesew A, Derese S, Midiwo JO, Heydenreich M, Peter MG. Effect of rotenoids from the seeds of Millettia dura on larvae ofAedes aegypti. Pest Manag Sci. 2003;59(10):1159–1161. doi: 10.1002/ps.740. [DOI] [PubMed] [Google Scholar]
- Yenesew A, Derese S, Midiwo JO, Oketch-Rabah HA, Lisgarten J, Palmer R, et al. Anti-plasmodial activities and X-ray crystal structures of rotenoids from Millettia usaramensis subspecies usaramensis. Phytochemistry. 2003;64(3):773–779. doi: 10.1016/S0031-9422(03)00373-X. [DOI] [PubMed] [Google Scholar]
- Yu O, McGonigle B. Metabolic engineering of isoflavone biosynthesis. Adv Agron. 2005;86:147–190. doi: 10.1016/S0065-2113(05)86003-1. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.










